Numerous clinical trials spanning early phase 1 through phase 4 investigate copper-related complexes for diagnostic and therapeutic applications across diverse medical conditions. Sponsored by academic universities, medical centers, and biotechnology entities, these studies target oncology indications—such as non-small cell lung carcinoma, head and neck squamous cell carcinoma, and prostate neoplasms—alongside non-oncology applications including amyotrophic lateral sclerosis and contraception. The overall portfolio encompasses various recruitment statuses, including active, recruiting, completed, terminated, and withdrawn studies.
| NCT Number | Recruitment | Conditions | Sponsor/Collaborators | Start Date | Phases |
|---|---|---|---|---|---|
| NCT06846489 | RECRUITING | Mantle Cell Lymphoma (MCL) |
Sun Yat-sen University |
2025-04-14 | PHASE2 |
| NCT05463133 | RECRUITING | Chronic Granulomatous Disease |
National Institute of Allergy and Infectious Diseases (NIAID) |
2022-07-08 | PHASE1; PHASE2 |
| NCT07659678 | NOT_YET_RECRUITING | Head and Neck Squamous Cell Carcinoma; Head and Neck Squamous Cell Carcinoma (HNSCC) - Recurrent/Metastatic (R/M); Head and Neck Squamous Cell Carcinoma HNSCC |
Washington University School of Medicine |
2026-08-31 | PHASE2 |
| NCT07789158 | NOT_YET_RECRUITING | Nasopharyngeal Carcinoma (NPC) |
Fudan University |
2026-09-01 | PHASE2 |
| NCT07649421 | NOT_YET_RECRUITING | Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) |
West China Hospital |
2026-08-01 | PHASE2 |
| NCT07381764 | NOT_YET_RECRUITING | Metastatic Colorectal Cancer (CRC) |
Gruppo Oncologico Italia Meridionale |
2026-03-30 | PHASE2 |
| NCT07681596 | RECRUITING | Relapsed or Refractory Multiple Myeloma |
AstraZeneca |
2026-07-27 | PHASE1; PHASE2 |
| NCT03093688 | RECRUITING | Non-small Cell Lung Cancer; Small Cell Lung Cancer; Pancreas Cancer; Hepatocellular Carcinoma; Gastric Cancer; Renal Cell Carcinoma |
Shanghai Public Health Clinical Center |
2017-03-01 | PHASE1; PHASE2 |
| NCT05616650 | RECRUITING | Prostatic Neoplasms; Prostate Cancer; Prostate Adenocarcinoma |
National Cancer Institute (NCI) |
2023-10-19 | PHASE2 |
| NCT07001618 | RECRUITING | NSCLC (Advanced Non-small Cell Lung Cancer) |
Gustave Roussy, Cancer Campus, Grand Paris |
2025-11-17 | PHASE2 |
| NCT07619365 | NOT_YET_RECRUITING | Breast Cancer; Advanced Breast Cancer; Metastatic Breast Cancer |
Washington University School of Medicine |
2026-08-31 | PHASE2 |
| NCT05469893 | RECRUITING | High-risk Smoldering Multiple Myeloma; Smoldering Multiple Myeloma; Multiple Myeloma |
Irene Ghobrial, MD |
2022-08-10 | PHASE2 |
| NCT05776381 | NOT_YET_RECRUITING | Shared Decision Making; Colonic Polyp; Decision Aids; Rectal Polyp; Colorectal Polyp; Colorectal Cancer |
Vejle Hospital |
2028-02-01 | PHASE2 |
| NCT04516135 | ACTIVE_NOT_RECRUITING | Metastatic Malignant Female Reproductive System Neoplasm |
M.D. Anderson Cancer Center |
2021-01-11 | PHASE2 |
| NCT06542250 | RECRUITING | B-cell Malignancies |
AstraZeneca |
2024-09-18 | PHASE1; PHASE2 |
| NCT05462613 | RECRUITING | Metastatic Colorectal Cancer |
Centre Hospitalier Universitaire de Besancon |
2023-05-09 | PHASE2; PHASE3 |
| NCT07716917 | NOT_YET_RECRUITING | Papillary Renal Carcinoma; Variant Histology Urothelial Carcinoma |
Alianza multidisciplinar para la investigación de los tumores genitourinarios -GUARD |
2026-10 | PHASE2 |
| NCT05489887 | RECRUITING | Neuroblastoma |
Giselle Sholler |
2022-09-14 | PHASE2 |
| NCT07104331 | RECRUITING | Epithelioid Hemangioendothelioma (EHE) |
Sarcoma Alliance for Research through Collaboration |
2026-02-24 | PHASE2 |
| NCT06866964 | RECRUITING | Germ Cell Tumor; Testicular Cancer |
Wake Forest University Health Sciences |
2025-08-28 | PHASE2 |
| NCT07627958 | NOT_YET_RECRUITING | Vaginal Microbial Diversity |
Seattle Children's Hospital |
2026-07 | |
| NCT07538804 | RECRUITING | Non-Small Cell Lung Cancer |
Avistone Biotechnology Co., Ltd. |
2026-07-10 | PHASE1; PHASE2 |
| NCT07621497 | NOT_YET_RECRUITING | Metastatic Colorectal Cancer (CRC) |
Sun Yat-sen University |
2026-06-01 | PHASE2 |
| NCT07612215 | RECRUITING | ER Positive, HER2 Positive Breast Cancer |
NYU Langone Health |
2026-05-13 | PHASE1; PHASE2 |
| NCT07362979 | RECRUITING | Nasopharyngeal Cancinoma (NPC) |
Sun Yat-sen University |
2026-03-12 | PHASE2 |
| NCT06769126 | RECRUITING | Extensive Stage Lung Small Cell Carcinoma; Lung Small Cell Carcinoma, A Subtype; Lung Small Cell Carcinoma, I Subtype; Lung Small Cell Carcinoma, N Subtype; Lung Small Cell Carcinoma, P Subtype |
SWOG Cancer Research Network |
2025-11-06 | PHASE2 |
| NCT07619599 | RECRUITING | Metastatic Lung Non-Small Cell Carcinoma; Metastatic Malignant Neoplasm in the Brain; Oligoprogressive Lung Non-Small Cell Carcinoma; Stage IV Lung Cancer AJCC v8 |
City of Hope Medical Center |
2026-09-14 | PHASE1 |
| NCT07101848 | NOT_YET_RECRUITING | Vulvar Cancers |
Hospital Israelita Albert Einstein |
2025-11-01 | PHASE2 |
| NCT03934905 | RECRUITING | Anthracycline Related Cardiotoxicity in Breast Cancer |
Texas Tech University Health Sciences Center |
2022-06-01 | PHASE1; PHASE2 |
| NCT07251582 | RECRUITING | Resectable Stage II-III Non-Small Cell Lung Cancer (NSCLC) |
Hunan Province Tumor Hospital |
2026-08-12 | PHASE3 |
| NCT05617716 | RECRUITING | Metastatic Neoplasm to the Spine; Metastatic Neoplasm |
University of Oklahoma |
2025-09-09 | PHASE2 |
| NCT06904378 | RECRUITING | Metastatic Pancreatic Ductal Adenocarcinoma |
Washington University School of Medicine |
2026-03-25 | PHASE1; PHASE2 |
| NCT07635524 | NOT_YET_RECRUITING | Prostate Cancer |
Hoag Memorial Hospital Presbyterian |
2026-08-01 | PHASE2 |
| NCT07489716 | RECRUITING | Non-Small Cell Lung Cancer |
Suzhou Suncadia Biopharmaceuticals Co., Ltd. |
2026-04-29 | PHASE2 |
| NCT07631325 | NOT_YET_RECRUITING | Unresectable Cutaneous Melanoma |
John Kirkwood |
2026-10-31 | PHASE1; PHASE2 |
| NCT07608627 | NOT_YET_RECRUITING | Locally Advanced Pancreatic Adenocarcinoma; Metastatic Pancreatic Adenocarcinoma; Stage III Pancreatic Cancer AJCC v8; Stage IV Pancreatic Cancer AJCC v8 |
City of Hope Medical Center |
2026-12-16 | PHASE1 |
| NCT07375758 | RECRUITING | Immunoglobulin A Nephropathy |
Beijing Mabworks Biotech Co., Ltd. |
2026-02-05 | PHASE1; PHASE2 |
| NCT07603050 | NOT_YET_RECRUITING | Gaucher Disease Type 3 |
Shanghai Vitalgen BioPharma Co., Ltd. |
2026-05-14 | PHASE1; PHASE2 |
| NCT07518979 | RECRUITING | Penile Cancer |
Jiyan Liu |
2026-07-22 | PHASE2 |
| NCT05751668 | SUSPENDED | Anatomic Stage IV Breast Cancer AJCC v8; Chemotherapy-Induced Peripheral Neuropathy; Metastatic Breast Carcinoma |
Alliance for Clinical Trials in Oncology |
2023-11-02 | PHASE2 |
| NCT05746208 | RECRUITING | Neuroendocrine Tumors; Well-Differentiated Neuroendocrine Carcinoma; High Grade Neuroendocrine Carcinoma, Any Site |
University of California, San Francisco |
2023-07-17 | PHASE2 |
| NCT06878859 | RECRUITING | Depression - Major Depressive Disorder; Cannabis Use Disorder; Mental Disorder |
Massachusetts General Hospital |
2026-02-23 | |
| NCT07480850 | ACTIVE_NOT_RECRUITING | Refractory Diffuse Large B-Cell Lymphoma (DLBCL) |
Cancer Institute and Hospital, Chinese Academy of Medical Sciences |
2026-01-01 | PHASE2 |
| NCT07398326 | RECRUITING | Colorectal Cancer |
Shanghai Changzheng Hospital |
2026-02-24 | PHASE2 |
| NCT06709417 | RECRUITING | Esophageal Squamous Cell Carcinoma (ESCC) |
Shanghai Chest Hospital |
2024-11-01 | PHASE2 |
| NCT07494448 | NOT_YET_RECRUITING | HER 2 Positive Advanced Breast Cancer; Breast Cancer |
MedSIR |
2026-07-01 | PHASE1; PHASE2 |
| NCT06968689 | RECRUITING | Pain |
The University of Texas Health Science Center, Houston |
2025-06-01 | |
| NCT03492762 | RECRUITING | Lung Inflammation |
Washington University School of Medicine |
2018-02-27 | EARLY_PHASE1 |
| NCT05048212 | RECRUITING | Brain Metastases; Renal Cell Carcinoma |
M.D. Anderson Cancer Center |
2022-09-20 | PHASE2 |
| NCT05472948 | RECRUITING | Adenocarcinoma of Small Intestine; Appendix Carcinoma; Metastatic |
Sun Yat-sen University |
2023-02-01 | PHASE2 |
| NCT06144671 | RECRUITING | Advanced Solid Tumors |
Grit Biotechnology |
2025-11-01 | PHASE1; PHASE2 |
| NCT07544784 | RECRUITING | Colorectal Cancer Liver Metastases (CRLM) |
Fudan University |
2025-11-04 | PHASE2 |
| NCT07024277 | NOT_YET_RECRUITING | Neuroendocrine Prostate Cancer |
Suzhou Zelgen Biopharmaceuticals Co.,Ltd |
2025-08 | PHASE2 |
| NCT07581184 | RECRUITING | Castration Resistant Metastatic Prostate Cancer; Prostate Cancer; mCRPC (Metastatic Castration-resistant Prostate Cancer); mCRPC; B7H3 |
Aktis Oncology, Inc. |
2026-07 | PHASE1 |
| NCT07020117 | RECRUITING | Urothelial Carcinoma Bladder; Triple Negative Breast Cancer (TNBC); Hormone Receptor Positive Breast Adenocarcinoma; Non Small Cell Lung Cancer; Cervical Adenocarcinoma; Colorectal Adenocarcinoma; Head and Neck Cancer |
Aktis Oncology, Inc. |
2025-08-22 | PHASE1 |
| NCT07241767 | RECRUITING | Lung Cancer |
Jiangsu HengRui Medicine Co., Ltd. |
2025-11-12 | PHASE2 |
| NCT06192615 | RECRUITING | Delirium |
Massachusetts General Hospital |
2025-01-06 | PHASE3 |
| NCT06356922 | ACTIVE_NOT_RECRUITING | Acute Leukemia |
Nantes University Hospital |
2024-10-22 | PHASE1; PHASE2 |
| NCT07647133 | NOT_YET_RECRUITING | Chronic Kidney Disease |
Shenzhen Salubris Pharmaceuticals Co., Ltd. |
2026-06-15 | PHASE2 |
| NCT06640725 | RECRUITING | Recurrent or Metastatic Squamous Cell Carcinoma of Head and Neck |
Groupe Oncologie Radiotherapie Tete et Cou |
2025-01-02 | PHASE2 |
| NCT06226662 | NOT_YET_RECRUITING | Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis |
NovelMed Therapeutics |
2026-06 | PHASE2 |
| NCT06435455 | NOT_YET_RECRUITING | Locally Advanced or Metastatic Solid Tumors Harboring KRAS G12C Mutation |
Suzhou Genhouse Bio Co., Ltd. |
2024-07-01 | PHASE1; PHASE2 |
| NCT07582796 | RECRUITING | Respiratory Syncytial Virus Infections |
Ab&B Bio-tech Co., Ltd.JS |
2026-05-14 | PHASE1; PHASE2 |
| NCT04082520 | RECRUITING | Grade 1 Meningioma; Grade 2 Meningioma; Grade 3 Meningioma; Recurrent Meningioma; Unresectable Meningioma |
Mayo Clinic |
2020-04-14 | PHASE2 |
| NCT05487391 | RECRUITING | Carcinoma, Non-Small-Cell Lung |
Qilu Pharmaceutical Co., Ltd. |
2022-12-08 | PHASE3 |
| NCT07662746 | RECRUITING | Head and Neck Cancer |
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University |
2026-07-01 | PHASE2 |
| NCT06942234 | RECRUITING | Inoperable Locally Advanced HER2-Negative Breast Cancer; Metastatic HER2-Negative Breast Cancer |
Jiangsu Alphamab Biopharmaceuticals Co., Ltd |
2025-06-01 | PHASE1; PHASE2 |
| NCT07765940 | NOT_YET_RECRUITING | Prostate Cancer |
RadAlliance Therapeutics, Inc |
2026-09-15 | PHASE1; PHASE2 |
| NCT07688343 | ACTIVE_NOT_RECRUITING | Dental Caries |
Mansoura University |
2025-06-01 | |
| NCT07192848 | NOT_YET_RECRUITING | Hepatocellular Carcinoma Non-resectable |
Song Peng |
2025-09 | PHASE2 |
| NCT06016855 | RECRUITING | Digestive System Neuroendocrine Tumor G1; Digestive System Neuroendocrine Tumor G2; Metastatic Digestive System Neuroendocrine Neoplasm; Metastatic Malignant Neoplasm in the Liver; Pancreatic Neuroendocrine Tumor G1; Pancreatic Neuroendocrine Tumor G2 |
Vanderbilt-Ingram Cancer Center |
2024-05-31 | PHASE4 |
| NCT02151084 | ACTIVE_NOT_RECRUITING | Biliary Tract Carcinoma; Gallbladder Carcinoma |
University Health Network, Toronto |
2014-11 | PHASE2 |
| NCT02420860 | ACTIVE_NOT_RECRUITING | Hematopoietic Cell Transplantation Recipient; Plasma Cell Myeloma |
M.D. Anderson Cancer Center |
2015-04-14 | PHASE2 |
| NCT05376878 | RECRUITING | Anatomic Stage IV Breast Cancer AJCC v8; Metastatic Breast Carcinoma; Metastatic Malignant Neoplasm in the Brain |
City of Hope Medical Center |
2022-12-21 | PHASE4 |
| NCT07646535 | NOT_YET_RECRUITING | Primary Aldosteronism |
Shenzhen Salubris Pharmaceuticals Co., Ltd. |
2026-06-12 | PHASE2 |
| NCT06126315 | RECRUITING | Amyotrophic Lateral Sclerosis |
Mario Negri Institute for Pharmacological Research |
2025-03-26 | PHASE2; PHASE3 |
| NCT07706361 | NOT_YET_RECRUITING | GHK and GHK-Cu Blood Levels |
LifeWave, Inc. |
2027-01 | |
| NCT06500247 | NOT_YET_RECRUITING | The Efficacy of Abiraterone Acetate Combined With Dalpicilib in the Treatment of Patients With Metastatic Castration-resistant Prostate Cancer |
Qilu Hospital of Shandong University |
2024-07-31 | PHASE2 |
| NCT05680558 | RECRUITING | Cutaneous T Cell Lymphoma; Mycosis Fungoides |
Columbia University |
2021-05-08 | PHASE2 |
| NCT07435753 | NOT_YET_RECRUITING | Burnout; Professional Fulfillment; Belonging; Intent to Leave; Leadership |
Colorado School of Public Health |
2026-03-01 | |
| NCT07437586 | RECRUITING | Acute Standardized Cutaneous Wounds (Punch-biopsy Wounds) |
Hudson Biotech |
2026-02-02 | PHASE2 |
| NCT07373613 | NOT_YET_RECRUITING | Essential Hypertension |
Boryung Pharmaceutical Co., Ltd |
2026-03-01 | PHASE2 |
| NCT06051123 | RECRUITING | ALSFTD; ALS (Amyotrophic Lateral Sclerosis); Frontal Temporal Dementia (FTD) |
Centre hospitalier de l'Université de Montréal (CHUM) |
2024-01-01 | |
| NCT06268093 | RECRUITING | Syringomyelia; Thalidomide |
Xuanwu Hospital, Beijing |
2024-02 | PHASE2 |
| NCT04195347 | RECRUITING | Acute Pancreatitis |
St. Jude Children's Research Hospital |
2020-09-04 | PHASE1; PHASE2 |
| NCT05129748 | RECRUITING | Ototoxic Hearing Loss |
Sunnybrook Health Sciences Centre |
2023-02-15 | PHASE2 |
| NCT06615102 | RECRUITING | Cardiac Surgery; Vasoplegia |
Universität Münster |
2025-03-31 | PHASE3 |
| NCT06353685 | RECRUITING | De-escalated Radiotherapy; Head and Neck Cancer |
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University |
2024-05-01 | PHASE2 |
| NCT04997317 | RECRUITING | Meningioma |
University Hospital, Basel, Switzerland |
2021-04-21 | PHASE1; PHASE2 |
| NCT03332238 | ACTIVE_NOT_RECRUITING | Rotator Cuff Tear; Muscle Atrophy; Tendon Tear |
Hospital for Special Surgery, New York |
2019-07-01 | PHASE2 |
| NCT07366333 | NOT_YET_RECRUITING | Well-being at Work |
University of Colorado, Denver |
2026-05-18 | |
| NCT07341958 | NOT_YET_RECRUITING | Ischemic Stroke or High-risk TIA (ABCD² ≥ 4) |
Beijing Tiantan Hospital |
2026-02-01 | |
| NCT05668858 | ACTIVE_NOT_RECRUITING | Squamous Cell Carcinoma of Head and Neck |
Sichuan Baili Pharmaceutical Co., Ltd. |
2023-02-10 | PHASE1; PHASE2 |
| NCT07198633 | RECRUITING | Advanced Prostate Cancer |
Qilu Pharmaceutical Co., Ltd. |
2025-11-05 | PHASE1; PHASE2 |
| NCT03243058 | WITHDRAWN | Diabetes Mellitus, Type 1; Diabetes; Diabetes, Autoimmune |
Jay S. Skyler |
2023-06 | PHASE1; PHASE2 |
| NCT06623656 | RECRUITING | Carcinoma, Non-Small-Cell Lung |
Weill Medical College of Cornell University |
2025-02-21 | PHASE2 |
| NCT06162650 | RECRUITING | Rectal Cancer |
National Cheng-Kung University Hospital |
2023-11-16 | PHASE2 |
| NCT05245786 | ACTIVE_NOT_RECRUITING | Locally Advanced Rectal Carcinoma; Stage III Rectal Cancer AJCC v8; Stage IIIA Rectal Cancer AJCC v8; Stage IIIB Rectal Cancer AJCC v8; Stage IIIC Rectal Cancer AJCC v8 |
City of Hope Medical Center |
2022-08-31 | EARLY_PHASE1 |
| NCT05728372 | WITHDRAWN | Metastatic Malignant Solid Neoplasm |
City of Hope Medical Center |
2023-08-25 | EARLY_PHASE1 |
| NCT07398859 | RECRUITING | Seasonal Allergic Rhinitis |
Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd. |
2026-03-19 | PHASE2 |
| NCT06107686 | RECRUITING | NSCLC; Breast Cancer; HNSCC; Locally Advanced or Metastatic Solid Tumors |
MediLink Therapeutics (Suzhou) Co., Ltd. |
2023-12-15 | PHASE2 |
| NCT02962063 | ACTIVE_NOT_RECRUITING | Esophageal Adenocarcinoma; Gastroesophageal Junction Adenocarcinoma |
Memorial Sloan Kettering Cancer Center |
2016-11 | PHASE1; PHASE2 |
| NCT06775249 | ENROLLING_BY_INVITATION | Winter Crew At Concordia Station |
Catholic University of the Sacred Heart |
2024-10-08 | |
| NCT06062823 | RECRUITING | NSCLC |
National University Hospital, Singapore |
2024-03-25 | PHASE2 |
| NCT06126822 | RECRUITING | Ebola Virus Disease |
Institute of Tropical Medicine, Belgium |
2025-02-25 | PHASE3 |
| NCT07124793 | NOT_YET_RECRUITING | EGFR Mutant NSCLC and Platinum Resistant Ovarian Cancer |
Innovent Biologics (Suzhou) Co. Ltd. |
2025-08-31 | PHASE2 |
| NCT06942910 | ACTIVE_NOT_RECRUITING | Chronic Kidney Disease With High Proteinuria |
AstraZeneca |
2025-05-07 | PHASE2 |
| NCT06156579 | RECRUITING | AML; MDS |
University Hospital Tuebingen |
2023-11-04 | PHASE2 |
| NCT04607954 | ACTIVE_NOT_RECRUITING | Platinum-Resistant Lung Small Cell Carcinoma; Platinum-Sensitive Lung Small Cell Carcinoma; Recurrent Extensive Stage Lung Small Cell Carcinoma; Refractory Extensive Stage Lung Small Cell Carcinoma |
Mayo Clinic |
2020-12-04 | PHASE2 |
| NCT06759064 | RECRUITING | Cancer of Stomach, Adenocarcinoma; Ascites, Malignant |
Qilu Hospital of Shandong University |
2024-09-12 | PHASE1; PHASE2 |
| NCT04082897 | ACTIVE_NOT_RECRUITING | CLL Transformation |
Niguarda Hospital |
2019-10-04 | PHASE2 |
| NCT06235151 | ACTIVE_NOT_RECRUITING | Prostate Cancer; Prostate Adenocarcinoma |
Curium US LLC |
2024-04-01 | PHASE3 |
| NCT04098744 | RECRUITING | CIN 2/3; HPV Infection; Pre-Cancerous Dysplasia; Cervical Dysplasia; HPV Related Disease |
Frantz Viral Therapeutics, LLC |
2020-09-09 | PHASE2 |
| NCT04304248 | UNKNOWN | Non Small Cell Lung Cancer |
Hao Long |
2019-08-01 | PHASE2 |
| NCT05504720 | COMPLETED | Esophagogastric Adenocarcinoma |
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest |
2023-02-13 | PHASE2 |
| NCT06283758 | RECRUITING | Hypertension; Blood Pressure; Cardiovascular Diseases |
Suzhou Municipal Hospital |
2024-03-01 | |
| NCT03480776 | ACTIVE_NOT_RECRUITING | Ovarian Cancer Prevention |
Canadian Cancer Trials Group |
2018-07-24 | PHASE2 |
| NCT06548763 | NOT_YET_RECRUITING | Endometrial Cancer |
Fudan University |
2024-11-30 | PHASE2 |
| NCT05870917 | ACTIVE_NOT_RECRUITING | Plasma Cell Leukemia |
Institute of Hematology & Blood Diseases Hospital, China |
2023-05-23 | PHASE2 |
| NCT04159168 | COMPLETED | Affective Symptoms; Empathy |
University of Alabama, Tuscaloosa |
2021-02-15 | |
| NCT06991478 | NOT_YET_RECRUITING | Solid Tumor, Malignant Ascites |
Tianjin Medical University Cancer Institute and Hospital |
2025-05-30 | PHASE1; PHASE2 |
| NCT05683145 | RECRUITING | Insomnia; Traumatic Brain Injury |
VA Eastern Colorado Health Care System |
2022-07-01 | |
| NCT04481204 | WITHDRAWN | Borderline Resectable Pancreatic Adenocarcinoma; Locally Advanced Pancreatic Ductal Adenocarcinoma; Resectable Pancreatic Ductal Adenocarcinoma |
M.D. Anderson Cancer Center |
2023-04-18 | PHASE2 |
| NCT06392815 | RECRUITING | Borrelia Burgdorferi Neuroborreliosis |
Rigshospitalet, Denmark |
2024-05-20 | |
| NCT06018688 | UNKNOWN | Non Small Cell Lung Cancer; EGFR Gene Mutation |
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University |
2023-09-15 | PHASE2 |
| NCT06196814 | NOT_YET_RECRUITING | Efficacy |
Hunan Province Tumor Hospital |
2024-10-01 | PHASE1; PHASE2 |
| NCT06155084 | RECRUITING | Metastatic Castration-resistant Prostate Cancer |
Hinova Pharmaceuticals Inc. |
2023-12-26 | PHASE1; PHASE2 |
| NCT04343573 | COMPLETED | Leptomeningeal Metastases |
Memorial Sloan Kettering Cancer Center |
2020-04-10 | PHASE2 |
| NCT05178576 | WITHDRAWN | Colon Cancer |
NSABP Foundation Inc |
2022-06-24 | PHASE2 |
| NCT03902184 | COMPLETED | Lymphoma, T-Cell; Lymphoma, T-Cell, Cutaneous; Mycosis Fungoides/Sezary Syndrome |
Innate Pharma |
2019-05-22 | PHASE2 |
| NCT05241249 | RECRUITING | Pancreas Cancer |
Susan E. Bates |
2022-02-01 | PHASE2 |
| NCT06700603 | NOT_YET_RECRUITING | Pancreatic Cancer |
Rui-hua Xu, MD, PhD |
2024-11-20 | PHASE2 |
| NCT06016062 | RECRUITING | Solid Tumor |
RemeGen Co., Ltd. |
2023-09-14 | PHASE1; PHASE2 |
| NCT05558982 | ACTIVE_NOT_RECRUITING | Metastatic Pancreatic Ductal Adenocarcinoma |
Georgetown University |
2023-08-16 | PHASE2 |
| NCT06245941 | TERMINATED | Myelofibrosis |
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. |
2024-05-13 | PHASE1; PHASE2 |
| NCT06715982 | RECRUITING | Immune Checkpoint Inhibitors (ICI)-Related Dermatitis |
Shixiu Wu |
2024-12-31 | PHASE2 |
| NCT05944978 | ACTIVE_NOT_RECRUITING | Relapsed/Refractory Chronic Lymphocytic Leukemia |
Sichuan Baili Pharmaceutical Co., Ltd. |
2023-08-16 | PHASE1; PHASE2 |
| NCT04334941 | ACTIVE_NOT_RECRUITING | Extensive Stage Lung Small Cell Carcinoma |
National Cancer Institute (NCI) |
2020-07-20 | PHASE2 |
| NCT04572815 | ACTIVE_NOT_RECRUITING | Hematologic and Lymphocytic Disorder; Hematopoietic and Lymphoid System Neoplasm |
Fred Hutchinson Cancer Center |
2021-05-14 | PHASE2 |
| NCT06145282 | ACTIVE_NOT_RECRUITING | Sickle Cell Disease |
National Heart, Lung, and Blood Institute (NHLBI) |
2023-12-28 | PHASE1; PHASE2 |
| NCT07509268 | COMPLETED | Diabetic Foot Ulcer |
Universidad Autonoma de Nuevo Leon |
2022-09-09 | PHASE2 |
| NCT06190782 | RECRUITING | Esophageal Squamous Cell Carcinoma; Oligometastatic Disease; Radiotherapy |
Fudan University |
2022-09-27 | PHASE3 |
| NCT06653881 | COMPLETED | Anterior Teeth Alignment Efficiency; Pain Perception; PGE2 Biomarker and Their Correlation |
Postgraduate Institute of Dental Sciences Rohtak |
2024-06-14 | |
| NCT06082440 | UNKNOWN | Osteoarthritis, Knee |
First Affiliated Hospital of Wannan Medical College |
2023-11-22 | EARLY_PHASE1 |
| NCT05992597 | RECRUITING | Rituximab, Lenalidomide, Zebutinib ，Mantle Cell Lymphoma |
Zhejiang Cancer Hospital |
2022-08-01 | PHASE2 |
| NCT03595683 | TERMINATED | Melanoma (Skin); Melanoma |
University of Chicago |
2018-10-02 | PHASE2 |
| NCT05824481 | ACTIVE_NOT_RECRUITING | Endometrial Cancer; Endometrial Adenocarcinoma |
Sun Yat-sen University |
2023-05-08 | PHASE2 |
| NCT07026682 | ACTIVE_NOT_RECRUITING | Acute Watery Diarrhea; Severe Acute Malnutrition in Childhood; Dehydration in Children |
University of Child Health Sciences and Children's Hospital, Lahore |
2025-02-10 | |
| NCT02179086 | ACTIVE_NOT_RECRUITING | Glioblastoma |
NRG Oncology |
2014-12-04 | PHASE2 |
| NCT05768035 | UNKNOWN | Hematological Malignancies |
Smart Immune SAS |
2023-06-06 | PHASE1; PHASE2 |
| NCT06475417 | UNKNOWN | Gastric Cancer |
Tang-Du Hospital |
2024-05-24 | PHASE2 |
| NCT04883749 | COMPLETED | Chronic Lymphoid Leukemia |
German CLL Study Group |
2021-06-01 | PHASE2 |
| NCT03895489 | COMPLETED | Osteoarthritis, Knee |
University of Alberta |
2019-09-09 | |
| NCT05953103 | TERMINATED | Subjects With Cerebral Hemorrhage |
Simcere Pharmaceutical Co., Ltd |
2023-07-03 | PHASE2 |
| NCT06437678 | UNKNOWN | Gastric Cancer |
Zhejiang Cancer Hospital |
2024-05-27 | PHASE2 |
| NCT06235099 | COMPLETED | Prostate Cancer; Prostate Adenocarcinoma; Biochemical Recurrence of Malignant Neoplasm of Prostate |
Curium US LLC |
2024-04-01 | PHASE3 |
| NCT06121674 | UNKNOWN | Erectile Dysfunction; Erectile Dysfunction Due to Venous Disorder |
Kasr El Aini Hospital |
2024-01 | |
| NCT06215651 | RECRUITING | Cadonilimab and Lenvatinib |
Peking Union Medical College Hospital |
2024-03-11 | PHASE2 |
| NCT03764540 | TERMINATED | Metastatic Prostate Cancer |
Centre hospitalier de l'Université de Montréal (CHUM) |
2019-04-01 | PHASE2 |
| NCT05597683 | UNKNOWN | Cytoreductive Surgery; Hyperthermic Intra-peritoneal Chemotherapy; Peritoneal Cancer |
Gangnam Severance Hospital |
2022-11-15 | |
| NCT04787354 | RECRUITING | Gastric Cancer |
Hallym University Medical Center |
2021-11-01 | PHASE3 |
| NCT04841434 | COMPLETED | CNS Lymphoma |
Charite University, Berlin, Germany |
2021-06-01 | PHASE1; PHASE2 |
| NCT05640609 | RECRUITING | Stomach Neoplasm |
West China Hospital |
2023-03-10 | PHASE1; PHASE2 |
| NCT03859713 | COMPLETED | Low Back Pain; Chronic Pain |
University of Utah |
2019-03-22 | |
| NCT05238324 | WITHDRAWN | Mucopolysaccharidosis II |
Homology Medicines, Inc |
2022-09-08 | PHASE1 |
| NCT01149083 | COMPLETED | Anatomic Stage III Breast Cancer AJCC v8; Anatomic Stage IV Breast Cancer AJCC v8; Locally Advanced Breast Carcinoma; Metastatic Breast Carcinoma; Unresectable Breast Carcinoma |
National Cancer Institute (NCI) |
2010-06-30 | PHASE2 |
| NCT05610826 | WITHDRAWN | Pancreatic Neuroendocrine Tumor; Pancreas Cancer |
University of Chicago |
2023-03-07 | PHASE1; PHASE2 |
| NCT03983668 | TERMINATED | Lymphoma |
Umar Farooq |
2020-01-31 | PHASE1; PHASE2 |
| NCT05580445 | UNKNOWN | Advanced Pancreatic Cancer |
Shouyao Holdings (Beijing) Co. LTD |
2022-08-11 | PHASE1; PHASE2 |
| NCT07077525 | COMPLETED | Type 2 Diabetes |
Al-Azhar University |
2023-06-01 | PHASE4 |
| NCT03951337 | UNKNOWN | Rectal Cancer |
Institut Cancerologie de l'Ouest |
2019-04-26 | PHASE2 |
| NCT05761470 | RECRUITING | Her-2 Negative Breast Cancer; HRR Gene Mutation |
Ying Lin |
2022-05-06 | PHASE2 |
| NCT04727658 | TERMINATED | Essential Tremor; Parkinsonian Disorders |
Centre Hospitalier Universitaire de Nice |
2021-07-01 | PHASE2 |
| NCT03561896 | COMPLETED | Brain Metastases, Adult; Cancer Brain |
Oncology Institute of Southern Switzerland |
2015-01 | |
| NCT06337071 | UNKNOWN | Meningococcal Meningitis |
Aimei Vacin BioPharm (Zhejiang) Co., Ltd. |
2024-03-20 | PHASE2 |
| NCT03542695 | COMPLETED | Breast Carcinoma; Calcification |
City of Hope Medical Center |
2021-11-03 | EARLY_PHASE1 |
| NCT05374785 | COMPLETED | Rheumatoid Arthritis |
Celon Pharma SA |
2022-05-01 | PHASE2 |
| NCT02715609 | COMPLETED | Glioblastoma Multiforme |
Washington University School of Medicine |
2016-06-15 | PHASE1; PHASE2 |
| NCT06060587 | WITHDRAWN | Prostate Cancer |
Northwestern University |
2023-10-19 | PHASE2 |
| NCT04437368 | TERMINATED | Dry Age-related Macular Degeneration |
Gyroscope Therapeutics Limited |
2019-04-26 | PHASE2 |
| NCT05611879 | UNKNOWN | NSCLC, Stage III |
Beijing Tsinghua Chang Gung Hospital |
2023-03-12 | PHASE2 |
| NCT03696277 | COMPLETED | Oligoprogressive Renal Cell Carcinoma |
University of Texas Southwestern Medical Center |
2018-10-01 | PHASE2 |
| NCT04951115 | TERMINATED | Small-cell Lung Cancer |
Weill Medical College of Cornell University |
2021-07-12 | PHASE2 |
| NCT05755685 | UNKNOWN | Peritoneal Metastases; Colorectal Cancer |
Second Affiliated Hospital, Zhejiang University, School of Medicine |
2023-02-10 | PHASE2 |
| NCT06108193 | UNKNOWN | Acne Vulgaris |
Chang Gung Memorial Hospital |
2023-07-11 | PHASE1; PHASE2 |
| NCT05268718 | UNKNOWN | Keratitis, Ulcerative; Antibiotic Resistance, Microbial; Photothermal Therapy |
Second Affiliated Hospital, Zhejiang University, School of Medicine |
2021-08-01 | EARLY_PHASE1 |
| NCT04912115 | SUSPENDED | Dyskinesias; Movement Disorders; Central Nervous System Diseases; Nervous System Diseases; Neurologic Manifestations |
PharmaTher Inc. |
2021-10-05 | PHASE2 |
| NCT05382910 | UNKNOWN | Asthma |
Shanghai Mabgeek Biotech.Co.Ltd |
2022-07-05 | PHASE1; PHASE2 |
| NCT00980954 | COMPLETED | Cervical Cancer |
Radiation Therapy Oncology Group |
2009-09 | PHASE3 |
| NCT05448898 | UNKNOWN | Olfactory Disorder |
Eye & ENT Hospital of Fudan University |
2022-07-15 | |
| NCT03981549 | COMPLETED | Central Retinal Vein Occlusion |
The Emmes Company, LLC |
2019-10-22 | PHASE1; PHASE2 |
| NCT04687423 | UNKNOWN | Advanced Solid Tumor |
Fochon Pharmaceuticals, Ltd. |
2021-04-13 | PHASE1 |
| NCT05447663 | TERMINATED | Acute Myeloid Leukemia; Allogeneic Stem Cell Transplantation |
Novartis Pharmaceuticals |
2023-02-23 | PHASE1; PHASE2 |
| NCT05132777 | UNKNOWN | Locally Advanced or Metastatic Non-Small Cell Lung Cancer; EGFR Exon20 Insertion Mutations |
Shanghai JMT-Bio Inc. |
2021-11-20 | PHASE2 |
| NCT05824455 | TERMINATED | Advanced Solid Tumors |
Shanghai Jun Pai Ying Shi Therapeutics Co., Ltd. |
2023-03-23 | PHASE1; PHASE2 |
| NCT04923776 | TERMINATED | Small-cell Lung Cancer |
Brian Henick, MD |
2021-09-20 | PHASE2 |
| NCT04769648 | UNKNOWN | Ocular Graft-versus-host Disease |
Glia, LLC |
2021-04-15 | PHASE2; PHASE3 |
| NCT05315713 | TERMINATED | Non-Hodgkin Lymphoma, Follicular Lymphoma |
Hoffmann-La Roche |
2022-05-10 | PHASE1; PHASE2 |
| NCT04297280 | COMPLETED | Hepatocellular Carcinoma |
Fudan University |
2020-04-29 | PHASE2 |
| NCT01236560 | COMPLETED | Brain Stem Glioma; Cerebral Astrocytoma; Childhood Cerebellar Anaplastic Astrocytoma; Childhood Cerebral Anaplastic Astrocytoma; Childhood Spinal Cord Neoplasm |
National Cancer Institute (NCI) |
2011-01-26 | PHASE2; PHASE3 |
| NCT03641664 | ACTIVE_NOT_RECRUITING | Behavior Problem; Mental Disorder; Emotional Problem |
Duke University |
2018-09-10 | |
| NCT05062070 | COMPLETED | Epidermolysis Bullosa Simplex |
BioMendics, LLC |
2022-05-05 | PHASE1 |
| NCT05613842 | COMPLETED | Prostate Cancer |
St Vincent's Hospital, Sydney |
2022-08-09 | PHASE2 |
| NCT03815461 | UNKNOWN | Locally Advanced Pancreatic Cancer |
Chinese Academy of Medical Sciences |
2019-02-01 | PHASE2 |
| NCT03289910 | ACTIVE_NOT_RECRUITING | Acute Myeloid Leukemia; Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome; Atypical Chronic Myeloid Leukemia; Chronic Myelomonocytic Leukemia; Essential Thrombocythemia; Myelodysplastic/Myeloproliferative Neoplasm; Myelofibrosis; Polycythemia Vera; Recurrent Acute Myeloid Leukemia; Refractory Acute Myeloid Leukemia |
National Cancer Institute (NCI) |
2018-09-24 | PHASE2 |
| NCT05653856 | COMPLETED | Metastasis From Malignant Tumor of Prostate (Disorder) |
Curium US LLC |
2022-12-05 | PHASE2 |
| NCT04687917 | ACTIVE_NOT_RECRUITING | Substance Use |
Ohio State University |
2021-01-14 | |
| NCT05322499 | UNKNOWN | Stage IV Esophagus Squamous Cell Carcinoma |
Zhejiang Cancer Hospital |
2022-04-15 | PHASE2 |
| NCT04843891 | UNKNOWN | Sarcoid; Cardiovascular Diseases; Cancer |
Ralph Weissleder, MD |
2021-09-06 | PHASE1 |
| NCT04487106 | COMPLETED | Recurrent Acute Myeloid Leukemia; Recurrent Chronic Myelomonocytic Leukemia; Recurrent Myelodysplastic Syndrome; Refractory Acute Myeloid Leukemia; Refractory Chronic Myelomonocytic Leukemia; Refractory Myelodysplastic Syndrome |
M.D. Anderson Cancer Center |
2020-07-21 | PHASE2 |
| NCT04806555 | UNKNOWN | Compartment Syndrome of Leg |
Kantonsspital Aarau |
2021-02-01 | |
| NCT04733963 | UNKNOWN | Colorectal Cancer |
Second Affiliated Hospital, Zhejiang University, School of Medicine |
2021-03-01 | PHASE2 |
| NCT02848196 | UNKNOWN | Adrenal Gland Metastases |
Istituto Clinico Humanitas |
2016-10-19 | |
| NCT03136809 | UNKNOWN | Amyotrophic Lateral Sclerosis |
Collaborative Medicinal Development Pty Limited |
2018-01-18 | PHASE1; PHASE2 |
| NCT05207904 | UNKNOWN | Non-Small Cell Squamous Lung Cancer; Brain Metastases |
Sun Yat-sen University |
2021-06-17 | PHASE2 |
| NCT04663763 | UNKNOWN | Locally Advanced Rectal Cancer |
Zhejiang Cancer Hospital |
2020-12-01 | PHASE2 |
| NCT05156645 | WITHDRAWN | COVID-19 |
Sinocelltech Ltd. |
2022-01-15 | PHASE1; PHASE2 |
| NCT02607215 | UNKNOWN | Metastatic Breast Cancer |
Fudan University |
2015-11 | PHASE2 |
| NCT04825418 | UNKNOWN | Hypothermia |
Seoul National University Hospital |
2021-05 | |
| NCT04686838 | COMPLETED | Dementia; Alzheimer Disease; Relationship, Marital; Caregiver Stress Syndrome |
Oregon Health and Science University |
2021-07-01 | |
| NCT05344248 | COMPLETED | Moderate to Severe Psoriasis |
Shanghai Junshi Bioscience Co., Ltd. |
2021-01-20 | PHASE1; PHASE2 |
| NCT03955224 | WITHDRAWN | Upper Aerodigestive Tract Neoplasms |
Institut Claudius Regaud |
2021-03 | PHASE2 |
| NCT04176848 | ACTIVE_NOT_RECRUITING | Breast Cancer |
Canadian Cancer Trials Group |
2020-08-10 | PHASE2 |
| NCT03727724 | COMPLETED | Carcinoma, Non-Small-Cell Lung |
The Netherlands Cancer Institute |
2018-12-04 | PHASE2 |
| NCT03890068 | COMPLETED | Soft Tissue Sarcoma |
Sun Yat-sen University |
2019-04-11 | PHASE2 |
| NCT04167618 | TERMINATED | Medulloblastoma, Childhood |
Y-mAbs Therapeutics |
2021-09-30 | PHASE1; PHASE2 |
| NCT02589782 | COMPLETED | Tuberculosis, Multidrug-Resistant; Extensively Drug-Resistant Tuberculosis; Tuberculosis, Pulmonary |
Medecins Sans Frontieres, Netherlands |
2017-01 | PHASE2; PHASE3 |
| NCT04696146 | COMPLETED | End Stage Renal Disease; Chronic Kidney Diseases |
Cedars-Sinai Medical Center |
2021-03-03 | PHASE1; PHASE2 |
| NCT03257150 | COMPLETED | Pancreatic Ductal Adenocarcinoma |
University Health Network, Toronto |
2017-09-22 | |
| NCT04461405 | COMPLETED | Type II Diabetes; Primary Health Care; Behavioral Health |
Oregon Health and Science University |
2020-03-01 | |
| NCT03559543 | COMPLETED | Colorectal Neoplasm; Intestinal Neoplasms; Gastrointestinal Neoplasms; Digestive System Neoplasm; Rectal Diseases; Colonic Diseases; Intestinal Disease; Gastrointestinal Disease; Digestive System Disease |
Catalysis SL |
2018-10-25 | PHASE2 |
| NCT03603795 | ACTIVE_NOT_RECRUITING | Acute Myeloid Leukemia |
French Innovative Leukemia Organisation |
2018-10-11 | PHASE2 |
| NCT04825938 | NOT_YET_RECRUITING | Salivary Gland Malignant Neoplasms; Salivary Gland Tumors |
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University |
2021-04-30 | PHASE2 |
| NCT04390958 | UNKNOWN | Esophageal Squamous Cell Carcinoma |
Chinese Academy of Medical Sciences |
2020-05-15 | PHASE2 |
| NCT04954326 | COMPLETED | Acute Lymphoblastic Leukemia |
Institut de Recherches Internationales Servier |
2021-05-07 | PHASE2 |
| NCT04605614 | WITHDRAWN | Hematopoietic and Lymphoid Cell Neoplasm; Malignant Solid Neoplasm |
City of Hope Medical Center |
2022-04-15 | PHASE1 |
| NCT02293954 | ACTIVE_NOT_RECRUITING | Breast Cancer; Colon Cancer; Extrahepatic Bile Duct Cancer; Gallbladder Cancer; Gastrointestinal Cancer; Liver and Intrahepatic Biliary Tract Cancer; Lung Cancer; Metastatic Cancer; Pancreatic Cancer; Rectal Cancer; Thyroid Gland Medullary Carcinoma; Unspecified Adult Solid Tumor, Protocol Specific |
City of Hope Medical Center |
2015-11-11 | |
| NCT04139317 | TERMINATED | Non-small Cell Lung Cancer (NSCLC) |
Novartis Pharmaceuticals |
2020-01-22 | PHASE2 |
| NCT04287920 | COMPLETED | Alcohol-related Liver Disease |
Mayo Clinic |
2020-09-21 | PHASE2 |
| NCT05042752 | UNKNOWN | Acute Heart Failure (AHF) |
Lara Palacios |
2021-01-01 | |
| NCT02229149 | TERMINATED | Breast Neoplasms; Malignant Tumor of the Breast |
US Oncology Research |
2014-12 | PHASE2 |
| NCT02226276 | ACTIVE_NOT_RECRUITING | Bone Metastases; HER2-positive Breast Cancer; Liver Metastases; Lung Metastases; Recurrent Breast Cancer; Soft Tissue Metastases; Stage IV Breast Cancer |
City of Hope Medical Center |
2015-01-07 | |
| NCT02617849 | UNKNOWN | Metastatic Malignant Melanoma |
Wilson Miller |
2016-05-19 | PHASE2 |
| NCT02420314 | COMPLETED | Carcinoma, Non-Small-Cell Lung |
Joseph J. Cullen, MD, FACS |
2015-04 | PHASE2 |
| NCT02684461 | COMPLETED | Non Small Cell Lung Cancer |
UNC Lineberger Comprehensive Cancer Center |
2016-09-13 | PHASE2 |
| NCT04313166 | COMPLETED | Amyotrophic Lateral Sclerosis |
Collaborative Medicinal Development Pty Limited |
2020-03-19 | PHASE2 |
| NCT02954055 | COMPLETED | Breast Cancer |
ETOP IBCSG Partners Foundation |
2017-09-13 | PHASE2 |
| NCT04079738 | TERMINATED | AML; AML, Adult |
H Scott Boswell |
2019-09-20 | PHASE1; PHASE2 |
| NCT03279692 | ACTIVE_NOT_RECRUITING | High Grade Meningioma |
Massachusetts General Hospital |
2017-11-07 | PHASE2 |
| NCT04684017 | UNKNOWN | SCLC; Anlotinib |
Shanghai Chest Hospital |
2019-05-01 | PHASE2 |
| NCT04570384 | COMPLETED | Acute Hypoxemic Respiratory Failure |
Asklepion Pharmaceuticals, LLC |
2020-10-15 | PHASE2 |
| NCT03254654 | COMPLETED | Advanced Triple-Negative Breast Cancer |
Fudan University |
2017-08-16 | PHASE2 |
| NCT03088033 | ACTIVE_NOT_RECRUITING | Heart Failure |
Corvia Medical |
2017-06-01 | |
| NCT02523313 | COMPLETED | Malignant Melanoma |
Prof. Dr. med. Dirk Schadendorf |
2015-09-02 | PHASE2 |
| NCT01325441 | COMPLETED | Cancer |
Sumitomo Pharma America, Inc. |
2011-04 | PHASE1; PHASE2 |
| NCT03954756 | UNKNOWN | Advanced Gastric Cancer |
Henan Cancer Hospital |
2019-06-01 | PHASE2 |
| NCT02417688 | COMPLETED | Carotid Atherosclerosis |
Washington University School of Medicine |
2015-04-05 | PHASE1 |
| NCT04446377 | COMPLETED | COVID-19 Disease |
OrphAI Therapeutics |
2020-07-15 | PHASE2 |
| NCT03102047 | COMPLETED | Rectal Cancer |
NSABP Foundation Inc |
2018-05-14 | PHASE2 |
| NCT03520985 | TERMINATED | Refractory Multiple Myeloma |
Swiss Cancer Institute |
2018-10-01 | PHASE2 |
| NCT04082832 | UNKNOWN | Amyotrophic Lateral Sclerosis |
Collaborative Medicinal Development Pty Limited |
2019-09-30 | PHASE2; PHASE3 |
| NCT01399918 | COMPLETED | Renal Cell Carcinoma |
Memorial Sloan Kettering Cancer Center |
2011-07 | PHASE2 |
| NCT04750382 | UNKNOWN | Triple-negative Breast Cancer |
Taizhou Hanzhong biomedical co. LTD |
2019-07-15 | PHASE1; PHASE2 |
| NCT02264210 | COMPLETED | Lung Neoplasms; Squamous Cell Lung Cancer; Adenocarcinoma of the Lung; Adenosquamous Cell Lung Cancer; Large Cell Lung Cancer; Bronchial Neoplasms; Stage IB Non-small Cell Lung Cancer |
Sun Yat-sen University |
2015-01 | PHASE2 |
| NCT04341389 | COMPLETED | COVID-19 |
Institute of Biotechnology, Academy of Military Medical Sciences, PLA of China |
2020-04-12 | PHASE2 |
| NCT03568461 | COMPLETED | Follicular Lymphoma |
Novartis Pharmaceuticals |
2018-11-12 | PHASE2 |
| NCT03074318 | TERMINATED | Metastatic Leiomyosarcoma; Metastatic Liposarcoma; Unresectable Leiomyosarcoma; Unresectable Liposarcoma |
Fred Hutchinson Cancer Center |
2017-09-28 | PHASE1; PHASE2 |
| NCT03995732 | UNKNOWN | Myocardial Reperfusion Injury |
Beijing Tide Pharmaceutical Co., Ltd |
2019-06-18 | PHASE2 |
| NCT03334058 | COMPLETED | Pemphigus Vulgaris; Pemphigus Foliaceus |
argenx |
2017-10-18 | PHASE2 |
| NCT04508816 | COMPLETED | Nasopharyngeal Carcinoma |
Fudan University |
2016-01-01 | PHASE2 |
| NCT01595061 | UNKNOWN | Stage III Vulvar Cancer AJCC v7; Stage IIIA Vulvar Cancer AJCC v7; Stage IIIB Vulvar Cancer AJCC v7; Stage IIIC Vulvar Cancer AJCC v7; Stage IVA Vulvar Cancer AJCC v7; Vulvar Squamous Cell Carcinoma |
Gynecologic Oncology Group |
2012-07-02 | PHASE2 |
| NCT03679624 | TERMINATED | Waldenstrom Macroglobulinemia; Waldenstrom's Disease; Waldenström; Hypergammaglobulinemia; Waldenstrom's Macroglobulinemia Recurrent; Waldenstrom's Macroglobulinemia of Lymph Nodes; Waldenstrom's Macroglobulinaemia, Without Mention of Remission; Waldenstrom's Macroglobulinemia Refractory |
Weill Medical College of Cornell University |
2020-07-30 | PHASE2 |
| NCT03850535 | TERMINATED | Acute Myeloid Leukemia |
Hoffmann-La Roche |
2019-03-25 | PHASE1; PHASE2 |
| NCT03620149 | TERMINATED | Bone Giant Cell Tumor |
European Organisation for Research and Treatment of Cancer - EORTC |
2019-09-26 | PHASE2 |
| NCT03490760 | TERMINATED | Adenocarcinoma of the Pancreas |
Baptist Health South Florida |
2018-11-09 | PHASE2 |
| NCT02827877 | ACTIVE_NOT_RECRUITING | HER2 Positive Breast Carcinoma; Stage IIIA Breast Cancer; Stage IIIB Breast Cancer; Stage IIIC Breast Cancer |
City of Hope Medical Center |
2016-07-15 | PHASE2 |
| NCT03057613 | COMPLETED | Squamous Cell Carcinoma of the Head and Neck |
Case Comprehensive Cancer Center |
2017-05-10 | PHASE2 |
| NCT04703543 | COMPLETED | Prostate Neoplasms |
Regina Elena Cancer Institute |
2017-06-22 | |
| NCT03825315 | COMPLETED | Plantar Fasciitis |
Revance Therapeutics, Inc. |
2018-12-31 | PHASE2 |
| NCT03620435 | UNKNOWN | Safety Issues |
McGill University Health Centre/Research Institute of the McGill University Health Centre |
2018-05-01 | PHASE2 |
| NCT02335827 | COMPLETED | Renal Tumor |
Fuda Cancer Hospital, Guangzhou |
2015-01-01 | |
| NCT03509298 | WITHDRAWN | Advanced Pancreatic Cancer |
Fuda Cancer Hospital, Guangzhou |
2018-04-12 | PHASE2 |
| NCT03637868 | WITHDRAWN | Metastatic Breast Cancer |
Institut Paoli-Calmettes |
2019-02-26 | PHASE2 |
| NCT02942758 | TERMINATED | Acute Myeloid Leukemia |
University Hospital Regensburg |
2017-04-10 | PHASE2 |
| NCT03845387 | COMPLETED | Parkinson Disease |
Kissei Pharmaceutical Co., Ltd. |
2019-02-26 | PHASE2 |
| NCT03328858 | TERMINATED | Brain Tumors |
Nicklaus Children's Hospital f/k/a Miami Children's Hospital |
2017-11-01 | |
| NCT05223296 | COMPLETED | Pile |
Jabir Ibn Hayyan Medical University |
2018-01-20 | |
| NCT01720225 | COMPLETED | Leukemia |
M.D. Anderson Cancer Center |
2012-11-06 | PHASE2 |
| NCT03635138 | UNKNOWN | Caries, Dental |
University of Chile |
2018-12-01 | |
| NCT03204929 | COMPLETED | Parkinson Disease |
Collaborative Medicinal Development Pty Limited |
2017-08-14 | PHASE1 |
| NCT04623242 | COMPLETED | Alzheimers Disease; Dementia; Alzheimers Disease, Familial |
Washington University School of Medicine |
2012-12 | PHASE2; PHASE3 |
| NCT03617913 | COMPLETED | Bladder Carcinoma Infiltrating the Muscle of the Bladder Wall; Stage II Bladder Cancer AJCC v8; Stage II Renal Pelvis Cancer AJCC v8; Stage II Ureter Cancer AJCC v8; Stage II Urethral Cancer AJCC v8; Stage III Bladder Cancer AJCC v8; Stage III Renal Pelvis Cancer AJCC v8; Stage III Ureter Cancer AJCC v8; Stage III Urethral Cancer AJCC v8; Stage IIIA Bladder Cancer AJCC v8; Stage IIIB Bladder Cancer AJCC v8; Urethral Urothelial Carcinoma |
Mayo Clinic |
2018-09-19 | PHASE2 |
| NCT00058422 | COMPLETED | Lymphoma |
Memorial Sloan Kettering Cancer Center |
2003-02-10 | PHASE2 |
| NCT02870634 | COMPLETED | Amyotrophic Lateral Sclerosis; Motor Neuron Disease |
Collaborative Medicinal Development Pty Limited |
2016-11-16 | PHASE1 |
| NCT01270724 | COMPLETED | CNS Germ Cell Tumor |
Nationwide Children's Hospital |
2010-08 | PHASE2 |
| NCT01940276 | COMPLETED | Prostate Cancer |
Duke University |
2013-10 | PHASE2 |
| NCT02816476 | COMPLETED | Amyloidosis |
University Hospital, Limoges |
2016-09 | PHASE2 |
| NCT03936426 | COMPLETED | Meningioma |
Clarity Pharmaceuticals Ltd |
2018-07-09 | PHASE1; PHASE2 |
| NCT03030677 | COMPLETED | Breastcancer; Phyllodes Breast Tumor |
Kasr El Aini Hospital |
2018-11-01 | |
| NCT03407976 | TERMINATED | Advanced Malignancies; Urothelial Carcinoma; MSI-H or dMMR Solid Tumors; Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma |
University of Utah |
2018-06-19 | PHASE1 |
| NCT01862003 | COMPLETED | Metastatic Colorectal Cancer; Recurrent Colorectal Cancer |
University College, London |
2014-05 | PHASE2 |
| NCT03040180 | UNKNOWN | Locally Advanced Rectal Cancer; Electrochemotherapy; Neoadjuvant Therapy; Down Staging |
Zealand University Hospital |
2017-01 | PHASE2 |
| NCT03039413 | COMPLETED | Bladder Urothelial Carcinoma; Urothelial Carcinoma |
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University |
2016-09-28 | EARLY_PHASE1 |
| NCT02989623 | COMPLETED | Prostate Cancer |
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University |
2015-09-01 | |
| NCT01939275 | COMPLETED | Adenocarcinoma of the Gastroesophageal Junction; Diffuse Adenocarcinoma of the Stomach; Intestinal Adenocarcinoma of the Stomach; Mixed Adenocarcinoma of the Stomach; Recurrent Gastric Cancer; Stage IA Gastric Cancer; Stage IB Gastric Cancer; Stage IIA Gastric Cancer; Stage IIB Gastric Cancer; Stage IIIA Gastric Cancer; Stage IIIB Gastric Cancer; Stage IIIC Gastric Cancer; Stage IV Gastric Cancer |
City of Hope Medical Center |
2014-11-19 | |
| NCT02395978 | COMPLETED | Major Depressive Disorder |
BioLite, Inc. |
2015-04-10 | PHASE2 |
| NCT02811354 | UNKNOWN | Carcinoma, Non-Small-Cell Lung |
National University Hospital, Singapore |
2017-02-24 | PHASE2 |
| NCT04930679 | COMPLETED | Diabetes Mellitus, Type 2 |
Centre of Clinical Pharmacology, Hanoi Medical University |
2018-11-24 | PHASE1 |
| NCT04136613 | COMPLETED | Contraception Behavior |
Taghreed Alhaidari |
2015-09-01 | |
| NCT01914484 | COMPLETED | Chronic Phase Chronic Myeloid Leukemia; Accelerated Phase Chronic Myeloid Leukemia; Blastic Phase Chronic Myeloid Leukemia; Philadelphia Positive Acute Lymphoblastic Leukemia; Resistant to Tyrosine Kinase Inhibitor Therapy |
University Health Network, Toronto |
2013-08-01 | PHASE1; PHASE2 |
| NCT02457910 | TERMINATED | Estrogen Receptor Negative; Estrogen Receptor Positive; HER2/Neu Negative; Progesterone Receptor Negative; Progesterone Receptor Positive; Stage IV Breast Cancer; Triple-Negative Breast Carcinoma |
Vanderbilt-Ingram Cancer Center |
2015-06 | PHASE1; PHASE2 |
| NCT02467413 | WITHDRAWN | Alzheimer's Disease; Vascular Dementia |
Botanicure Co., Ltd. |
2017-01-30 | PHASE2 |
| NCT01266603 | COMPLETED | Melanoma |
M.D. Anderson Cancer Center |
2011-02-22 | PHASE2 |
| NCT01093612 | ACTIVE_NOT_RECRUITING | Breast Cancer; Stage IV Breast Cancer |
City of Hope Medical Center |
2011-03-16 | |
| NCT02729896 | COMPLETED | Lymphoma |
Hoffmann-La Roche |
2016-11-09 | PHASE1; PHASE2 |
| NCT02069080 | TERMINATED | Cancer |
National Institute of Allergy and Infectious Diseases (NIAID) |
2014-02-20 | EARLY_PHASE1 |
| NCT03034135 | COMPLETED | Recurrent Glioblastoma |
Cantex Pharmaceuticals |
2017-03-09 | PHASE2 |
| NCT03214887 | WITHDRAWN | Peripheral Arterial Occlusive Disease; Critical Limb Ischemia |
Academia Sinica, Taiwan |
2017-01-17 | PHASE1; PHASE2 |
| NCT03134352 | COMPLETED | Eczema |
Zai Lab Pty. Ltd. |
2017-04-26 | PHASE2 |
| NCT02607124 | TERMINATED | High Grade Glioma; Diffuse Intrinsic Pontine Glioma; Bithalamic High Grade Glioma |
Children's Hospital Medical Center, Cincinnati |
2016-04 | PHASE1; PHASE2 |
| NCT02100423 | COMPLETED | Contiguous Stage II Small Lymphocytic Lymphoma; Noncontiguous Stage II Small Lymphocytic Lymphoma; Stage 0 Chronic Lymphocytic Leukemia; Stage I Chronic Lymphocytic Leukemia; Stage I Small Lymphocytic Lymphoma; Stage II Chronic Lymphocytic Leukemia |
Paolo Caimi, MD |
2014-10-16 | PHASE2 |
| NCT01079013 | UNKNOWN | Non Hodgkin Lymphoma; Hodgkin Lymphoma |
Sheba Medical Center |
2010-03 | PHASE2 |
| NCT01258855 | COMPLETED | Metastatic Melanoma; Recurrent Melanoma; Stage III Cutaneous Melanoma AJCC v7; Stage IIIA Cutaneous Melanoma AJCC v7; Stage IIIB Cutaneous Melanoma AJCC v7; Stage IIIC Cutaneous Melanoma AJCC v7; Stage IV Cutaneous Melanoma AJCC v6 and v7 |
National Cancer Institute (NCI) |
2011-01-18 | PHASE2 |
| NCT03230539 | UNKNOWN | Contraception |
Population Council |
2017-05-01 | PHASE1 |
| NCT02745678 | COMPLETED | Colitis, Ulcerative |
Stanford University |
2016-01 | PHASE1 |
| NCT03016117 | COMPLETED | Anesthesia, Local |
San Salvatore Hospital of L'Aquila |
2017-03-15 | |
| NCT02708511 | TERMINATED | Ovarian Carcinoma; Breast Carcinoma |
Sanjiv Sam Gambhir |
2016-08 | PHASE1 |
| NCT04482465 | COMPLETED | Age-related Macular Degeneration; Vitamin D Deficiency |
Universitaire Ziekenhuizen KU Leuven |
2017-04-20 | |
| NCT02963610 | TERMINATED | Relapsed or Refractory Solid Tumors; Nonsmall Cell Lung Cancer |
Fox Chase Cancer Center |
2017-03-29 | PHASE1; PHASE2 |
| NCT01588145 | COMPLETED | Non Small Cell Lung Cancer |
Hanmi Pharmaceutical Company Limited |
2012-03 | PHASE1; PHASE2 |
| NCT02469701 | TERMINATED | Non-small Cell Lung Cancer; Lung Cancer; Metastatic Lung Cancer; NSCLC |
howard safran |
2016-02 | PHASE2 |
| NCT02735798 | WITHDRAWN | Brain Metastases; Documented Her2 Overexpression; Advanced Solid Tumor; Neurologically Stable |
Pamela Munster |
2016-04 | EARLY_PHASE1 |
| NCT03210649 | COMPLETED | Dyslipidemia |
Chong Kun Dang Pharmaceutical |
2017-03-07 | PHASE1 |
| NCT00731588 | COMPLETED | Neonatal Anemia |
John A Widness |
2008-06 | PHASE2 |
| NCT02005419 | COMPLETED | Stage IA Pancreatic Adenocarcinoma; Stage IB Pancreatic Adenocarcinoma; Stage IIA Pancreatic Adenocarcinoma; Stage IIB Pancreatic Adenocarcinoma |
Xian-Jun Yu |
2013-12 | PHASE2 |
| NCT02941198 | COMPLETED | Intrauterine Systems; Postpartum Immediate Contraception |
Zeynep Kamil Maternity and Pediatric Research and Training Hospital |
2016-06-01 | |
| NCT01041781 | TERMINATED | Lung Cancer |
Alliance for Clinical Trials in Oncology |
2010-02 | PHASE3 |
| NCT02333058 | COMPLETED | Acute Lymphoblastic Leukaemias (ALL); Acute Myeloid Leukaemias (AML); Myelodysplastic Syndromes (MDS); Juvenile Myelomonocytic Leukaemias (JMML) |
medac GmbH |
2014-11-21 | PHASE2 |
| NCT01878084 | COMPLETED | Bone Loss; Vertical Alveolar Bone Loss; Horizontal Alveolar Bone Loss |
Alexandria University |
2013-10 | |
| NCT01188889 | WITHDRAWN | Chronic Myeloid Leukemia |
University of Michigan Rogel Cancer Center |
2013-09 | PHASE1; PHASE2 |
| NCT01932697 | COMPLETED | Human Papillomavirus Infection; Stage I Oropharyngeal Squamous Cell Carcinoma; Stage II Oropharyngeal Squamous Cell Carcinoma; Stage III Oropharyngeal Squamous Cell Carcinoma; Stage IVA Oropharyngeal Squamous Cell Carcinoma; Stage IVB Oropharyngeal Squamous Cell Carcinoma |
Mayo Clinic |
2013-09-04 | PHASE2 |
| NCT01975363 | COMPLETED | Atypical Ductal Breast Hyperplasia; BRCA1 Gene Mutation; BRCA2 Gene Mutation; Ductal Breast Carcinoma in Situ; Lobular Breast Carcinoma in Situ |
Ohio State University Comprehensive Cancer Center |
2013-06 | |
| NCT01534260 | COMPLETED | Acute Myeloid Leukemia |
Hamid Sayar |
2012-02-10 | PHASE1; PHASE2 |
| NCT02842177 | COMPLETED | Contraception |
Assiut University |
2016-01 | |
| NCT02161679 | WITHDRAWN | Triple-negative Breast Cancer |
Gilead Sciences |
2016-08 | PHASE2 |
| NCT00525785 | COMPLETED | Stomach Cancer; Gastric Cancer |
M.D. Anderson Cancer Center |
2004-01 | PHASE2 |
| NCT00972478 | ACTIVE_NOT_RECRUITING | Ann Arbor Stage II Non-Hodgkin Lymphoma; Ann Arbor Stage III Non-Hodgkin Lymphoma; Ann Arbor Stage IV Non-Hodgkin Lymphoma |
National Cancer Institute (NCI) |
2010-11-15 | PHASE1; PHASE2 |
| NCT02016274 | UNKNOWN | Esophageal Squamous Cell Cancer |
Shen Lin |
2013-12 | PHASE2 |
| NCT02039778 | TERMINATED | Glioblastoma; Malignant Glioma; Brain Tumors; Anaplastic Astrocytoma |
Beth Israel Medical Center |
2013-12 | |
| NCT01130701 | WITHDRAWN | Pancreatic Cancer |
University of Massachusetts, Worcester |
2010-05 | PHASE2 |
| NCT01399047 | COMPLETED | Juvenile Neuronal Ceroid Lipofuscinosis |
University of Rochester |
2011-07 | PHASE2 |
| NCT02203149 | COMPLETED | Hepatitis C |
Merck Sharp & Dohme LLC |
2014-08-01 | PHASE2; PHASE3 |
| NCT02487836 | COMPLETED | Adenocarcinoma of Head of Pancreas |
Institut Paoli-Calmettes |
2013-10 | PHASE2 |
| NCT02689856 | COMPLETED | Hemorrhoids |
Citius Pharmaceuticals, Inc. |
2015-05 | PHASE2 |
| NCT01619774 | COMPLETED | Melanoma |
M.D. Anderson Cancer Center |
2012-09 | PHASE2 |
| NCT02474186 | COMPLETED | Breast Cancer; Metastatic Breast Cancer; Solid Tumor |
NYU Langone Health |
2003-04 | PHASE2 |
| NCT02097238 | COMPLETED | Recurrent Osteosarcoma |
National Cancer Institute (NCI) |
2014-08 | PHASE2 |
| NCT01967576 | COMPLETED | Pheochromocytoma; Paraganglioma |
National Cancer Institute (NCI) |
2013-10-19 | PHASE2 |
| NCT01757847 | COMPLETED | Binge-Eating Disorder |
VA Office of Research and Development |
2013-01 | |
| NCT01498588 | TERMINATED | Breast Neoplasms; Breast Cancer; Breast Tumors; Cancer of the Breast; Neoplasms, Breast; Tumors, Breast |
Emory University |
2011-11 | PHASE2 |
| NCT02292472 | COMPLETED | Hypertrophy of Masseter Muscle |
Medy-Tox |
2014-10-06 | PHASE2 |
| NCT02498379 | COMPLETED | Atherosclerosis |
Washington University School of Medicine |
2014-10 | EARLY_PHASE1 |
| NCT02023112 | COMPLETED | Hepatitis C Virus |
AbbVie |
2014-01 | PHASE3 |
| NCT01404650 | COMPLETED | Gastrointestinal Stromal Tumor |
SCRI Development Innovations, LLC |
2011-12 | PHASE2 |
| NCT00087685 | COMPLETED | Endometrial Cancer |
M.D. Anderson Cancer Center |
2004-06 | PHASE2 |
| NCT01029678 | COMPLETED | Non Small Cell Lung Cancer |
University Hospital, Limoges |
2010-01 | PHASE2 |
| NCT01306032 | COMPLETED | Ovarian Cancer; Primary Peritoneal Cancer; Serous Carcinoma Cancer; Triple-Negative Breast Cancer; Fallopian Tube Cancer |
National Cancer Institute (NCI) |
2011-01-12 | PHASE2 |
| NCT01309997 | COMPLETED | Graft Versus Host Disease; Systemic Scleroderma |
Lee, Stephanie |
2011-03 | PHASE2 |
| NCT01594424 | COMPLETED | End Stage Renal Disease (ESRD) |
Cedars-Sinai Medical Center |
2012-06 | PHASE1; PHASE2 |
| NCT01082211 | COMPLETED | Breast Cancer |
Radiation Therapy Oncology Group |
2010-06 | PHASE2 |
| NCT00413478 | TERMINATED | Chronic Lymphocytic Leukemia; Leukemia |
M.D. Anderson Cancer Center |
2006-09 | PHASE2 |
| NCT02139371 | COMPLETED | Breast Cancer; Prostate Cancer; Urinary Bladder Cancer |
Rigshospitalet, Denmark |
2014-05 | EARLY_PHASE1 |
| NCT00313729 | COMPLETED | CNS Tumor, Adult |
University of California, San Francisco |
1999-05 | PHASE2 |
| NCT01262820 | COMPLETED | Lung Cancer |
UNC Lineberger Comprehensive Cancer Center |
2010-12 | PHASE2 |
| NCT02603965 | COMPLETED | Prostate Adenocarcinoma; Stage IIB Prostate Cancer; Stage III Prostate Cancer; Stage IV Prostate Cancer |
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University |
2013-08 | PHASE1 |
| NCT00948935 | COMPLETED | Biliary Cancer; Cholangiocarcinoma |
Abramson Cancer Center at Penn Medicine |
2009-04 | PHASE2 |
| NCT01472029 | COMPLETED | Adenocarcinoma of the Gastroesophageal Junction; Adenocarcinoma of the Stomach |
AIO-Studien-gGmbH |
2011-12 | PHASE2 |
| NCT01614938 | UNKNOWN | Nasopharyngeal Carcinoma |
Fudan University |
2010-08 | PHASE2 |
| NCT01880515 | COMPLETED | Skin Rash; Lung Cancer |
Instituto Nacional de Cancerologia de Mexico |
2010-12 | PHASE2 |
| NCT01258998 | COMPLETED | Adult Nasal Type Extranodal NK/T-cell Lymphoma; Anaplastic Large Cell Lymphoma; Angioimmunoblastic T-cell Lymphoma; B-cell Adult Acute Lymphoblastic Leukemia; B-cell Chronic Lymphocytic Leukemia; Cutaneous B-cell Non-Hodgkin Lymphoma; Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue; Hepatosplenic T-cell Lymphoma; Intraocular Lymphoma; Nodal Marginal Zone B-cell Lymphoma; Noncutaneous Extranodal Lymphoma; Peripheral T-cell Lymphoma; Recurrent Adult Acute Lymphoblastic Leukemia; Recurrent Adult Diffuse Large Cell Lymphoma; Recurrent Adult Diffuse Mixed Cell Lymphoma; Recurrent Adult Diffuse Small Cleaved Cell Lymphoma; Recurrent Adult Grade III Lymphomatoid Granulomatosis; Recurrent Adult Hodgkin Lymphoma; Recurrent Adult Immunoblastic Large Cell Lymphoma; Recurrent Adult Lymphoblastic Lymphoma; Recurrent Adult T-cell Leukemia/Lymphoma; Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma; Recurrent Grade 1 Follicular Lymphoma; Recurrent Grade 2 Follicular Lymphoma; Recurrent Grade 3 Follicular Lymphoma; Recurrent Mantle Cell Lymphoma; Recurrent Marginal Zone Lymphoma; Recurrent Mycosis Fungoides/Sezary Syndrome; Recurrent Small Lymphocytic Lymphoma; Refractory Hairy Cell Leukemia; Small Intestine Lymphoma; Splenic Marginal Zone Lymphoma; T-cell Adult Acute Lymphoblastic Leukemia; T-cell Large Granular Lymphocyte Leukemia; Testicular Lymphoma; Waldenström Macroglobulinemia |
National Cancer Institute (NCI) |
2010-12 | PHASE2 |
| NCT01484626 | TERMINATED | Multiple Myeloma |
Loyola University |
2011-05-05 | PHASE1; PHASE2 |
| NCT04737278 | COMPLETED | Neuralgia; Myalgia |
Mitosynergy LLC |
2014-01-28 | PHASE1; PHASE2 |
| NCT01378143 | COMPLETED | Colorectal Cancer |
Oncozyme Pharma Inc. |
2011-03 | PHASE2 |
| NCT01326923 | TERMINATED | Head and Neck Squamous Cell Cancer |
Louisiana State University Health Sciences Center Shreveport |
2010-06 | PHASE2 |
| NCT01663285 | TERMINATED | Urothelial Cancer; Bladder Cancer |
University of Michigan Rogel Cancer Center |
2012-09 | PHASE2 |
| NCT01220895 | COMPLETED | Cytomegalovirus Infection |
Cell Medica Ltd |
2010-10 | PHASE2 |
| NCT01402180 | UNKNOWN | Esophageal Squamous Cell Carcinoma |
Fudan University |
2010-12 | PHASE2; PHASE3 |
| NCT01656720 | COMPLETED | Faecal Incontinence |
Norgine |
2012-02 | PHASE2 |
| NCT01502982 | COMPLETED | Diffuse Large B-Cell Lymphoma |
Nordic Lymphoma Group |
2004-11 | PHASE2 |
| NCT01379274 | TERMINATED | MDS |
Rush University Medical Center |
2011-01 | PHASE2 |
| NCT02745639 | COMPLETED | Rectal Neoplasms |
IRCCS Azienda Ospedaliero-Universitaria di Bologna |
2010-02 | PHASE2 |
| NCT00517530 | COMPLETED | Lymphoma |
Hoffmann-La Roche |
2007-09 | PHASE1; PHASE2 |
| NCT00053352 | COMPLETED | Childhood Embryonal Tumor; Childhood Extracranial Germ Cell Tumor; Childhood Extragonadal Germ Cell Tumor; Childhood Malignant Ovarian Germ Cell Tumor; Childhood Malignant Testicular Germ Cell Tumor; Childhood Teratoma; Ovarian Embryonal Carcinoma; Ovarian Yolk Sac Tumor; Stage II Malignant Testicular Germ Cell Tumor; Stage IIA Ovarian Germ Cell Tumor; Stage IIB Ovarian Germ Cell Tumor; Stage IIC Ovarian Germ Cell Tumor; Stage III Malignant Testicular Germ Cell Tumor; Stage IIIA Ovarian Germ Cell Tumor; Stage IIIB Ovarian Germ Cell Tumor; Stage IIIC Ovarian Germ Cell Tumor; Testicular Choriocarcinoma and Yolk Sac Tumor; Testicular Embryonal Carcinoma |
Children's Oncology Group |
2003-11-03 | PHASE3 |
| NCT01426438 | COMPLETED | HIV-1 Infection |
Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections |
2011-11 | PHASE2 |
| NCT01528826 | UNKNOWN | Breast Cancer |
Fudan University |
2011-12 | PHASE2 |
| NCT00887575 | COMPLETED | Breast Cancer |
SCRI Development Innovations, LLC |
2009-06 | PHASE1; PHASE2 |
| NCT01669460 | COMPLETED | Fatigue |
University Health Network, Toronto |
2012-07 | PHASE2 |
| NCT00815295 | COMPLETED | Squamous Cell Cancer |
Duke University |
2008-01 | PHASE1; PHASE2 |
| NCT01929421 | COMPLETED | Advanced Colorectal Cancer |
Gachon University Gil Medical Center |
2009-12 | PHASE2 |
| NCT01262274 | TERMINATED | Breast Neoplasms |
Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan |
2010-12 | PHASE2 |
| NCT00617591 | COMPLETED | Multiple Myeloma |
H. Lee Moffitt Cancer Center and Research Institute |
2008-01 | PHASE2 |
| NCT01633645 | COMPLETED | Non Small Cell Lung Cancer; Metastatic |
University Hospital of Crete |
2009-06 | PHASE2 |
| NCT00179309 | COMPLETED | Breast Cancer |
National Cancer Institute (NCI) |
2005-09 | PHASE2 |
| NCT00810719 | COMPLETED | Pancreatic Cancer |
University of California, Davis |
2009-04 | PHASE2 |
| NCT01542255 | TERMINATED | Metastatic Melanoma |
Dartmouth-Hitchcock Medical Center |
2010-06 | PHASE2 |
| NCT01304277 | COMPLETED | Fabry Disease |
Shire |
2011-11-17 | PHASE2 |
| NCT00803010 | COMPLETED | Acute Graft Versus Host Disease |
H. Lee Moffitt Cancer Center and Research Institute |
2008-09 | PHASE2 |
| NCT01268280 | TERMINATED | Myasthenia Gravis |
Cytokinetics |
2010-12 | PHASE2 |
| NCT00670046 | TERMINATED | Prostate Cancer |
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins |
2008-05 | PHASE2 |
| NCT01649024 | UNKNOWN | Malignant Mesothelioma |
Azienda Ospedaliera Universitaria Senese |
2009-05 | PHASE2 |
| NCT01081574 | COMPLETED | Allergic Rhinoconjunctivitis; Chronic Urticaria |
Faes Farma, S.A. |
2010-01 | PHASE1; PHASE2 |
| NCT00123968 | COMPLETED | HIV Infections |
National Institute of Allergy and Infectious Diseases (NIAID) |
2006-05 | PHASE1; PHASE2 |
| NCT00413192 | COMPLETED | Soft Tissue Sarcoma |
Eisai Inc. |
2007-01 | PHASE2 |
| NCT01072175 | COMPLETED | Cancer |
Novartis Pharmaceuticals |
2010-03-26 | PHASE2 |
| NCT00818558 | COMPLETED | Non Small Cell Lung Cancer |
Centre Hospitalier Universitaire de Nice |
2008-11-03 | |
| NCT00684021 | COMPLETED | Left Ventricular Dysfunction |
The University of Texas Health Science Center, Houston |
2008-07 | PHASE2 |
| NCT01513278 | COMPLETED | Radiation Induced Dermatitis |
Apeiron Biologics |
2012-01 | PHASE1; PHASE2 |
| NCT02810873 | TERMINATED | Breast Carcinoma |
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University |
2008-09 | |
| NCT00360672 | COMPLETED | Acute Myelogenous Leukemia; Myelodysplastic Syndrome |
M.D. Anderson Cancer Center |
2009-01 | PHASE2 |
| NCT01467921 | UNKNOWN | Curatively-resected, Node-positive Esophageal Squamous Cell Carcinoma |
Samsung Medical Center |
2010-12 | PHASE2 |
| NCT00918385 | TERMINATED | Prostate Cancer |
Duke University |
2009-05 | PHASE2 |
| NCT00794339 | TERMINATED | Cervical Cancer |
American College of Radiology |
2009-07-29 | PHASE2 |
| NCT01371240 | WITHDRAWN | Pancreas Cancer |
University Hospitals Cleveland Medical Center |
2011-06 | EARLY_PHASE1 |
| NCT01010295 | COMPLETED | Non-Hodgkin Lymphoma |
International Extranodal Lymphoma Study Group (IELSG) |
2006-09 | PHASE2 |
| NCT00714948 | TERMINATED | Bladder Cancer; URINARY BLADDER |
Memorial Sloan Kettering Cancer Center |
2008-07 | PHASE2 |
| NCT01249521 | UNKNOWN | Metastatic Colorectal Cancer |
Austin Health |
2010-11 | PHASE2 |
| NCT00544778 | TERMINATED | Sarcoma |
City of Hope Medical Center |
2001-08 | PHASE2 |
| NCT01229332 | COMPLETED | Parkinson's Disease |
NeuroDerm Ltd. |
2011-01 | PHASE1; PHASE2 |
| NCT01198626 | TERMINATED | Community-Acquired Bacterial Pneumonia (CABP) |
Furiex Pharmaceuticals, Inc |
2010-10 | PHASE2 |
| NCT01154374 | COMPLETED | Diabetic Foot Ulcers |
Skingenix, Inc. |
2010-11 | PHASE2 |
| NCT00895297 | TERMINATED | Chronic Myeloid Leukemia |
European Society for Blood and Marrow Transplantation |
2010-02 | PHASE2 |
| NCT00398710 | COMPLETED | Waldenström's Macroglobulinemia |
AEterna Zentaris |
2006-10 | PHASE2 |
| NCT01320917 | UNKNOWN | Contraception Desired; Obesity |
University of Sao Paulo |
2009-02 | PHASE4 |
| NCT00504153 | COMPLETED | Recurrent Colon Cancer; Recurrent Rectal Cancer; Stage IV Colon Cancer; Stage IV Rectal Cancer |
National Cancer Institute (NCI) |
2007-07 | PHASE2 |
| NCT00860808 | COMPLETED | Tinnitus |
Auris Medical AG |
2009-03 | PHASE2 |
| NCT00714649 | COMPLETED | Head and Neck Cancer |
Cliniques universitaires Saint-Luc- Université Catholique de Louvain |
2008-07 | PHASE1; PHASE2 |
| NCT00660582 | COMPLETED | Metastatic Colorectal Cancer |
Per Pfeiffer |
2008-04 | PHASE2 |
| NCT00022490 | TERMINATED | Leukemia |
OHSU Knight Cancer Institute |
2001-06 | PHASE2 |
| NCT00169247 | COMPLETED | Larynx Cancer; Hypopharynx Cancer |
Groupe Oncologie Radiotherapie Tete et Cou |
2005-10 | PHASE2 |
| NCT00462280 | COMPLETED | Precancerous Condition; Stage 0 Melanoma; Stage I Melanoma; Stage II Melanoma |
National Cancer Institute (NCI) |
2007-05 | PHASE2 |
| NCT00748358 | COMPLETED | Prostatic Neoplasms; Neoplasms, Hormone-Dependent; Tumor Markers, Biological; Survival Rate; Disease-Free Survival |
Assistance Publique - Hôpitaux de Paris |
2008-03 | PHASE2 |
| NCT00049543 | COMPLETED | Adenocarcinoma of the Lung; Adenosquamous Cell Lung Cancer; Bronchoalveolar Cell Lung Cancer; Large Cell Lung Cancer; Squamous Cell Lung Cancer; Stage IB Non-small Cell Lung Cancer; Stage IIA Non-small Cell Lung Cancer; Stage IIB Non-small Cell Lung Cancer; Stage IIIA Non-small Cell Lung Cancer |
National Cancer Institute (NCI) |
2002-09 | PHASE3 |
| NCT00682747 | TERMINATED | Radiation-induced Xerostomia |
Thomas Kuhnt |
2008-05 | PHASE2 |
| NCT00089583 | COMPLETED | Infection, Human Immunodeficiency Virus I |
ViiV Healthcare |
2004-07 | PHASE2 |
| NCT01115075 | COMPLETED | Healthy |
Pennington Biomedical Research Center |
2010-03 | |
| NCT00514020 | COMPLETED | Gastric Cancer |
Vanderbilt-Ingram Cancer Center |
2007-08 | PHASE2 |
| NCT00858806 | COMPLETED | Chronic Myeloid Leukemia |
Università degli Studi di Brescia |
2008-04 | PHASE2 |
| NCT00315133 | COMPLETED | Type 1 Diabetes Mellitus |
University of Sao Paulo |
2003-12 | PHASE1; PHASE2 |
| NCT00634595 | UNKNOWN | Head and Neck Squamous Carcinoma; Nasopharyngeal Carcinoma |
Sun Yat-sen University |
2008-03 | PHASE2 |
| NCT00925938 | COMPLETED | Cervical Priming |
Ferring Pharmaceuticals |
2010-01 | PHASE2 |
| NCT00967746 | COMPLETED | Contraception |
Organon and Co |
2009-11 | PHASE2 |
| NCT00910221 | COMPLETED | Acute Kidney Dysfunction |
Austin Health |
2008-03 | PHASE2; PHASE3 |
| NCT00524589 | TERMINATED | Prostate Cancer |
Roswell Park Cancer Institute |
2006-04 | PHASE2 |
| NCT00919880 | COMPLETED | Breast Cancer |
Tao OUYANG |
2009-07 | PHASE2 |
| NCT00792467 | COMPLETED | Hodgkin's Lymphoma |
Italfarmaco |
2008-02 | PHASE1; PHASE2 |
| NCT00601718 | COMPLETED | Adult Nasal Type Extranodal NK/T-cell Lymphoma; Anaplastic Large Cell Lymphoma; Angioimmunoblastic T-cell Lymphoma; Contiguous Stage II Mantle Cell Lymphoma; Cutaneous B-cell Non-Hodgkin Lymphoma; Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue; Nodal Marginal Zone B-cell Lymphoma; Noncontiguous Stage II Mantle Cell Lymphoma; Recurrent Adult Burkitt Lymphoma; Recurrent Adult Diffuse Large Cell Lymphoma; Recurrent Adult Diffuse Mixed Cell Lymphoma; Recurrent Adult Diffuse Small Cleaved Cell Lymphoma; Recurrent Adult Grade III Lymphomatoid Granulomatosis; Recurrent Adult Hodgkin Lymphoma; Recurrent Adult Immunoblastic Large Cell Lymphoma; Recurrent Adult Lymphoblastic Lymphoma; Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma; Recurrent Grade 1 Follicular Lymphoma; Recurrent Grade 2 Follicular Lymphoma; Recurrent Grade 3 Follicular Lymphoma; Recurrent Mantle Cell Lymphoma; Recurrent Marginal Zone Lymphoma; Recurrent Mycosis Fungoides/Sezary Syndrome; Recurrent Small Lymphocytic Lymphoma; Splenic Marginal Zone Lymphoma; Stage I Cutaneous T-cell Non-Hodgkin Lymphoma; Stage I Mantle Cell Lymphoma; Stage I Mycosis Fungoides/Sezary Syndrome; Stage II Cutaneous T-cell Non-Hodgkin Lymphoma; Stage II Mycosis Fungoides/Sezary Syndrome; Stage III Cutaneous T-cell Non-Hodgkin Lymphoma; Stage III Mantle Cell Lymphoma; Stage III Mycosis Fungoides/Sezary Syndrome; Stage IV Cutaneous T-cell Non-Hodgkin Lymphoma; Stage IV Mantle Cell Lymphoma; Stage IV Mycosis Fungoides/Sezary Syndrome; Waldenström Macroglobulinemia |
University of Washington |
2007-12 | PHASE1; PHASE2 |
| NCT00267748 | COMPLETED | Carcinoma, Renal Cell |
Pfizer |
2005-12 | PHASE2 |
| NCT00573326 | UNKNOWN | Systemic Sclerosis |
Azienda Ospedaliera Universitaria Policlinico |
2009-02 | PHASE2 |
| NCT00405938 | COMPLETED | Breast Cancer; Breast Neoplasms |
SCRI Development Innovations, LLC |
2006-11 | PHASE2 |
| NCT01372813 | TERMINATED | Advanced Clear Cell Renal Carcinoma |
National Cancer Institute (NCI) |
2007-12 | PHASE2 |
| NCT00550654 | TERMINATED | Kidney Cancer; Melanoma (Skin); Metastatic Cancer; Ovarian Cancer; Sarcoma; Unspecified Adult Solid Tumor, Protocol Specific |
National Institutes of Health Clinical Center (CC) |
2007-10 | PHASE2 |
| NCT00578110 | UNKNOWN | Glaucoma |
Synabridge Corporation |
2008-01 | |
| NCT00087438 | COMPLETED | Lung Cancer |
Radiation Therapy Oncology Group |
2004-05 | PHASE2 |
| NCT00739388 | COMPLETED | Leukemia |
Swiss Cancer Institute |
2008-07 | PHASE2 |
| NCT00455533 | COMPLETED | Breast Cancer |
Bristol-Myers Squibb |
2007-10 | PHASE2 |
| NCT00209690 | COMPLETED | Esophageal Cancer |
Hokkaido Gastrointestinal Cancer Study Group |
2003-10 | PHASE1; PHASE2 |
| NCT00906061 | UNKNOWN | Carcinoma, Non-Small-Cell Lung |
Hospital Arnau de Vilanova |
2007-10 | PHASE2 |
| NCT00784394 | COMPLETED | Healthy, no Evidence of Disease |
National Cancer Institute (NCI) |
2004-04 | PHASE1 |
| NCT00598611 | COMPLETED | Chronic Urticaria |
Charite University, Berlin, Germany |
2007-09 | PHASE3 |
| NCT00884767 | UNKNOWN | Chemotherapeutic Agent Toxicity; Colorectal Cancer; Neurotoxicity |
Institut Cancerologie de l'Ouest |
2007-09 | PHASE2 |
| NCT00577317 | TERMINATED | Lymphedema; Stage 0 Cervical Cancer; Stage 0 Uterine Corpus Cancer; Stage 0 Vulvar Cancer; Stage I Uterine Corpus Cancer; Stage I Vulvar Cancer; Stage IA Cervical Cancer; Stage IB Cervical Cancer; Stage II Uterine Corpus Cancer; Stage II Vulvar Cancer; Stage IIA Cervical Cancer; Stage IIB Cervical Cancer; Stage III Cervical Cancer; Stage III Uterine Corpus Cancer; Stage III Vulvar Cancer; Stage IV Uterine Corpus Cancer; Stage IVA Cervical Cancer; Stage IVB Cervical Cancer; Stage IVB Vulvar Cancer |
Gynecologic Oncology Group |
2007-12 | PHASE3 |
| NCT00072176 | COMPLETED | Endometrial Adenocarcinoma; Endometrial Adenosquamous Cell Carcinoma; Endometrial Clear Cell Carcinoma; Endometrial Papillary Serous Carcinoma; Recurrent Endometrial Carcinoma; Stage IIIA Endometrial Carcinoma; Stage IIIB Endometrial Carcinoma; Stage IIIC Endometrial Carcinoma; Stage IVA Endometrial Carcinoma; Stage IVB Endometrial Carcinoma |
National Cancer Institute (NCI) |
2004-05 | PHASE2 |
| NCT00354549 | COMPLETED | Lung Cancer |
Swiss Cancer Institute |
2006-01 | PHASE2 |
| NCT00481676 | COMPLETED | Chronic Urticaria |
Novartis |
2007-05 | PHASE2 |
| NCT00318110 | TERMINATED | Metastatic Renal Cell Carcinoma |
Center for International Blood and Marrow Transplant Research |
2006-04 | PHASE2 |
| NCT00562185 | WITHDRAWN | Ovarian Cancer |
University of Texas Southwestern Medical Center |
2008-05 | PHASE1; PHASE2 |
| NCT00123760 | COMPLETED | Brain Neoplasms; Lung Neoplasms; Thyroid Neoplasms; Colorectal Neoplasms; Lymphoma |
AHS Cancer Control Alberta |
2004-02 | PHASE2; PHASE3 |
| NCT00193037 | COMPLETED | Breast Cancer |
SCRI Development Innovations, LLC |
2001-02 | PHASE2 |
| NCT00463073 | COMPLETED | Malignant Gliomas |
Rigshospitalet, Denmark |
2006-08 | PHASE2 |
| NCT00528645 | COMPLETED | Extensive Stage Small Cell Lung Cancer; Lung Metastases; Malignant Pleural Effusion; Recurrent Small Cell Lung Cancer |
National Cancer Institute (NCI) |
2007-11 | PHASE2 |
| NCT00498953 | COMPLETED | Head and Neck Cancer |
European Organisation for Research and Treatment of Cancer - EORTC |
2007-05 | PHASE1; PHASE2 |
| NCT00084617 | COMPLETED | Adenocarcinoma of the Gastroesophageal Junction; Diffuse Adenocarcinoma of the Stomach; Intestinal Adenocarcinoma of the Stomach; Mixed Adenocarcinoma of the Stomach; Recurrent Gastric Cancer; Stage IIIA Gastric Cancer; Stage IIIB Gastric Cancer; Stage IIIC Gastric Cancer; Stage IV Gastric Cancer |
National Cancer Institute (NCI) |
2004-03 | PHASE2 |
| NCT00391989 | COMPLETED | Lymphoblastic Leukemia, Acute |
Gruppo Italiano Malattie EMatologiche dell'Adulto |
2006-09 | PHASE2 |
| NCT00365209 | COMPLETED | Healthy, no Evidence of Disease; Tobacco Use Disorder |
National Cancer Institute (NCI) |
2006-10 | PHASE2 |
| NCT00381810 | TERMINATED | Lupus Erythematosus, Systemic |
Genentech, Inc. |
2006-06-22 | PHASE3 |
| NCT00430300 | TERMINATED | Pulmonary Disease, Chronic Obstructive |
Pfizer |
2007-01 | PHASE2 |
| NCT00510874 | COMPLETED | Influenza |
GlaxoSmithKline |
2007-07-28 | PHASE1 |
| NCT00490685 | COMPLETED | Carcinoma, Hepatocellular |
Istituto Clinico Humanitas |
2007-04 | PHASE2 |
| NCT00617188 | COMPLETED | Ovarian Cancer |
Masonic Cancer Center, University of Minnesota |
2007-06 | PHASE2 |
| NCT00214149 | TERMINATED | Breast Cancer |
University of Wisconsin, Madison |
2004-10 | PHASE2 |
| NCT00360035 | COMPLETED | Myelofibrosis |
Gemin X |
2006-07 | PHASE2 |
| NCT00128921 | TERMINATED | Multiple Myeloma |
University of Arkansas |
2006-04 | PHASE2 |
| NCT00365417 | COMPLETED | Breast Cancer |
NSABP Foundation Inc |
2006-08 | PHASE2 |
| NCT00619996 | COMPLETED | Prostate Cancer |
Italian Trial in Medical Oncology |
2007-03 | PHASE2 |
| NCT00091390 | COMPLETED | Prostate Cancer |
Radiation Therapy Oncology Group |
2004-07 | PHASE2 |
| NCT00337987 | COMPLETED | Peripheral T-Cell Lymphoma |
Yale University |
2005-11 | PHASE2 |
| NCT00853398 | TERMINATED | Osteoarthritis of the Knee |
Smith & Nephew Orthopaedics AG |
2004-10 | PHASE4 |
| NCT00336648 | COMPLETED | Pancreatic Neoplasms |
M.D. Anderson Cancer Center |
2006-06 | PHASE2 |
| NCT00419263 | COMPLETED | Influenza |
BioCryst Pharmaceuticals |
2007-01 | PHASE2 |
| NCT00232609 | COMPLETED | Wheelchair Users |
VA Pittsburgh Healthcare System |
2005-08 | PHASE2 |
| NCT00239343 | COMPLETED | Breast Cancer |
AstraZeneca |
2004-10 | PHASE2 |
| NCT00359450 | TERMINATED | Non-small Cell Lung Cancer |
Bristol-Myers Squibb |
2006-07 | PHASE2 |
| NCT00307710 | COMPLETED | Lymphoma |
M.D. Anderson Cancer Center |
2004-08 | PHASE2 |
| NCT00113438 | COMPLETED | Cancer; Tumor |
Mateon Therapeutics |
2005-03 | PHASE2 |
| NCT00653757 | COMPLETED | Prostate Cancer |
Mayo Clinic |
2002-03 | PHASE1; PHASE2 |
| NCT00494949 | COMPLETED | Hypotension; Hypoxia |
Sangart |
2003-04 | PHASE1; PHASE2 |
| NCT00040755 | COMPLETED | Adenocarcinoma of the Prostate; Bone Metastases; Hormone-resistant Prostate Cancer; Recurrent Prostate Cancer; Stage IV Prostate Cancer |
National Cancer Institute (NCI) |
2002-05 | PHASE2 |
| NCT00532285 | TERMINATED | Breast Cancer |
National Cancer Center, Korea |
2005-09 | PHASE2 |
| NCT00045695 | COMPLETED | Lymphoma |
NCIC Clinical Trials Group |
2002-08 | PHASE2 |
| NCT00139243 | COMPLETED | Squamous Cell Carcinoma; Carcinoma of Head and/or Neck |
Dana-Farber Cancer Institute |
1997-10 | PHASE1; PHASE2 |
| NCT00233623 | WITHDRAWN | Metastatic Colorectal Cancer |
AstraZeneca |
2004-07 | PHASE2 |
| NCT02262858 | COMPLETED | Healthy |
Boehringer Ingelheim |
2005-08 | PHASE1 |
| NCT00005596 | COMPLETED | Leukemia |
Children's Oncology Group |
2000-04 | PHASE3 |
| NCT00053248 | COMPLETED | Leukemia |
OHSU Knight Cancer Institute |
2002-10 | PHASE1; PHASE2 |
| NCT00042978 | COMPLETED | Extensive Stage Small Cell Lung Cancer; Recurrent Small Cell Lung Cancer |
National Cancer Institute (NCI) |
2003-04 | PHASE2 |
| NCT00494338 | TERMINATED | Metastatic Prostate Cancer |
Sanofi |
2004-11 | PHASE2 |
| NCT00187226 | COMPLETED | Central Nervous System Tumors; Brain Tumors |
St. Jude Children's Research Hospital |
1997-06 | PHASE2 |
| NCT00026182 | COMPLETED | Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue; Nodal Marginal Zone B-cell Lymphoma; Recurrent Grade 1 Follicular Lymphoma; Recurrent Grade 2 Follicular Lymphoma; Recurrent Mantle Cell Lymphoma; Recurrent Small Lymphocytic Lymphoma; Splenic Marginal Zone Lymphoma |
National Cancer Institute (NCI) |
2001-10 | PHASE2 |
| NCT00081133 | COMPLETED | Leukemia |
Memorial Sloan Kettering Cancer Center |
2003-12 | PHASE1; PHASE2 |
| NCT00054249 | COMPLETED | Gastric Cancer |
University Hospitals Seidman Cancer Center |
2002-09 | PHASE2 |
| NCT00005820 | COMPLETED | Prostate Cancer |
Alliance for Clinical Trials in Oncology |
2000-05 | PHASE2 |
| NCT02170974 | COMPLETED | Healthy |
Boehringer Ingelheim |
2004-07 | PHASE1 |
| NCT00058552 | COMPLETED | Ovarian Cancer |
Genentech, Inc. |
2003-05 | PHASE2 |
| NCT00003077 | COMPLETED | Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm |
Alliance for Clinical Trials in Oncology |
1995-10 | PHASE1; PHASE2 |
| NCT00005810 | COMPLETED | Prostate Cancer |
Alliance for Clinical Trials in Oncology |
2000-03 | PHASE2 |
| NCT01693718 | COMPLETED | Head and Neck |
University of Chicago |
2003-03 | PHASE2 |
| NCT00057850 | COMPLETED | Head and Neck Cancer |
National Cancer Institute (NCI) |
2002-01 | PHASE1; PHASE2 |
| NCT00010218 | COMPLETED | Lung Cancer |
Alliance for Clinical Trials in Oncology |
2001-04 | PHASE2 |
| NCT00015977 | COMPLETED | Prostate Cancer |
University of Chicago |
2001-11 | PHASE2 |
| NCT00003454 | TERMINATED | Stage IV Breast Cancer |
Burzynski Research Institute |
1996-03-18 | PHASE2 |
| NCT00006890 | COMPLETED | Multiple Myeloma and Plasma Cell Neoplasm |
NCIC Clinical Trials Group |
2000-07-12 | PHASE2 |
| NCT00003682 | TERMINATED | Prostate Cancer |
UNICANCER |
1998-10 | PHASE3 |
| NCT00004104 | COMPLETED | Melanoma (Skin) |
NYU Langone Health |
1998-06 | PHASE2 |
| NCT00003760 | COMPLETED | Pancreatic Cancer |
The University of Texas Health Science Center at San Antonio |
1998-11 | PHASE2 |
| NCT00117182 | COMPLETED | Lung Diseases, Obstructive |
Syntara |
2005-07 | PHASE2 |
| NCT00180921 | UNKNOWN | Cancer of the Head and Neck; Carcinoma, Adenoid Cystic |
Gustave Roussy, Cancer Campus, Grand Paris |
2004-07 | PHASE2 |
| NCT00070447 | COMPLETED | Lymphoma |
National Cancer Institute (NCI) |
2003-11 | PHASE2 |
| NCT00064363 | COMPLETED | Brain and Central Nervous System Tumors |
National Institutes of Health Clinical Center (CC) |
2003-06 | PHASE2 |
| NCT00269958 | COMPLETED | Anemia |
Janssen-Ortho Inc., Canada |
PHASE2 | |
| NCT00367718 | WITHDRAWN | Nasopharyngeal Carcinoma |
Johns Hopkins University |
PHASE2 | |
| NCT00002233 | COMPLETED | HIV Infections |
Glaxo Wellcome |
PHASE2 | |
| NCT00307749 | COMPLETED | Diabetic Polyneuropathy |
Tanabe Pharma Corporation |
2006-03 | PHASE2 |
| NCT00002917 | COMPLETED | Bladder Cancer |
Mary Babb Randolph Cancer Center at West Virginia University Hospitals |
1996-11 | PHASE1; PHASE2 |
| NCT00076518 | COMPLETED | HIV Infections; Hypertriglyceridemia |
National Institute of Allergy and Infectious Diseases (NIAID) |
PHASE2 | |
| NCT00115635 | COMPLETED | Prostate Cancer |
Herlev Hospital |
2005-03 | PHASE1; PHASE2 |
| NCT00246597 | TERMINATED | Anemia; Breast Neoplasms; Hemoglobins; Quality of Life; Chemotherapy, Adjuvant |
Ortho Biotech Products, L.P. |
2002-12 | PHASE3 |
| NCT00006268 | COMPLETED | Brain and Central Nervous System Tumors |
New Approaches to Brain Tumor Therapy Consortium |
2000-10 | PHASE1; PHASE2 |
| NCT00002003 | COMPLETED | Lymphoma, Non-Hodgkin; HIV Infections |
Lederle Laboratories |
PHASE2 | |
| NCT00020345 | COMPLETED | Stage IVA Pancreatic Cancer; Stage III Pancreatic Cancer; Adenocarcinoma of the Pancreas |
National Institutes of Health Clinical Center (CC) |
2000-09 | PHASE2 |
| NCT00004158 | COMPLETED | Multiple Myeloma and Plasma Cell Neoplasm |
Fred Hutchinson Cancer Center |
1999-06 | PHASE1; PHASE2 |
| NCT00547846 | COMPLETED | Acute Cough |
PhytoHealth Corporation |
2007-10 | PHASE2 |
| NCT00335712 | COMPLETED | Type 2 Diabetes Mellitus |
Ono Pharma USA Inc |
2006-06 | PHASE2 |
| NCT00157599 | COMPLETED | Deep Vein Thrombosis |
McMaster University |
2002-01 | |
| NCT00002188 | COMPLETED | Sarcoma, Kaposi; HIV Infections |
Anderson Clinical Research |
PHASE2 | |
| NCT00093366 | COMPLETED | Leukemia; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Diseases |
Fred Hutchinson Cancer Center |
2004-06 | PHASE1; PHASE2 |
| NCT00354497 | UNKNOWN | Prostate Cancer |
Lawrence Livermore National Laboratory at University of California |
2002-03 | PHASE2 |
| NCT00019097 | COMPLETED | Stage II Multiple Myeloma; Stage III Multiple Myeloma; Refractory Plasma Cell Neoplasm |
National Cancer Institute (NCI) |
1995-07 | PHASE2 |
| NCT00003327 | UNKNOWN | Head and Neck Cancer |
Theradex |
1997-09 | PHASE2 |
| NCT00004900 | COMPLETED | Breast Cancer |
Hackensack Meridian Health |
1999-10 | PHASE2 |
| NCT00004333 | COMPLETED | Tyrosinemia, Type I |
National Center for Research Resources (NCRR) |
1994-11 | PHASE2 |
| NCT00209664 | SUSPENDED | Gastric Cancer |
Hokkaido Gastrointestinal Cancer Study Group |
2004-01 | PHASE2 |
| NCT00275119 | UNKNOWN | Pancreatic Cancer |
GERCOR - Multidisciplinary Oncology Cooperative Group |
2003-11 | PHASE2 |
(data from https://clinicaltrials.gov, updated on 2025-06-03)
Check the
Cu(II)-Elesclomol
product page for in-depth specifications, including solubility, stock solutions, MOA, and working concentrations.
Mechanism and Biochemical Profile
Appendix RUO and cGMP Quality Standards
| Quality Dimension | RUO (Research Use Only) | cGMP (Current Good Manufacturing Practice) |
|---|---|---|
| Clinical Applicability | Prohibited in human clinical trials or medical diagnostics. | Mandatory for human clinical trials (Phase I–III) and therapies. |
| Regulatory Status | Non-regulated grade; exempt from drug manufacturing laws. | Legally enforced by health authorities (e.g., FDA, EMA, NMPA). |
| Facility Environment | Unclassified analytical or research laboratories. | Validated Cleanrooms (ISO Class 5–8) with continuous monitoring. |
| Quality Control | Basic purity and activity testing. | Rigorous safety release testing (Sterility, Endotoxin, Mycoplasma). |
| Process Validation | Basic equipment calibration; no process validation required. | Full qualification (IQ/OQ/PQ) and complete batch records. |
| Quality Assurance | Vendor self-declared without required formal QMS. | Mandatory QA/QC unit, Change Control, CAPA, and vendor audits. |
| Regulatory Impact | High risk of IND rejection if used as a critical raw material. | Required for IND/NDA filings, supported by Drug Master Files (DMF). |
Footnotes
Regulatory Note: Governed by FDA (21 CFR Parts 210/211/312), EMA (EudraLex Vol 4), ICH Guidelines (E6/Q7/Q9/Q10), and compendial standards (USP <71>/<85>/<1043>).
Note: Technical data last updated: Sep 1, 2026.